The following table shows a list of patent term extension applications filed with Japanese Patent Office from 2006 to 2010.
The list includes patent term extension application numbers, patent numbers, Drug names. The drug names were translated from Japanese to English by machine translation.
○: Application
■: Granted
| Application No. | Patent No. | Drugs |
|---|---|---|
| 2010-700201 (○) | 4210355 | Tolvaptan (Name: Samsca Tablets 15 mg) |
| 2010-700201 (■) | 4210355 | Tolvaptan (Name: Samsca Tablets 15 mg) |
| 2010-700200 (○) | 2905909 | Tolvaptan (Name: Samsca Tablets 15 mg) |
| 2010-700200 (■) | 2905909 | Tolvaptan (Name: Samsca Tablets 15 mg) |
| 2010-700199 (○) | 2805255 | Common Name: Metaflumizone (Sale Name: Promelis Dog) |
| 2010-700199 (■) | 2805255 | Metaflumizone, Amitraz and N, N-Diethyl-m-Toluamide (Deet) Sale Name: Promelis Dog |
| 2010-700198 (○) | 3813875 | Eltrombopag Olamine |
| 2010-700198 (■) | 3813875 | Eltrombopag Olamine |
| 2010-700197 (○) | 3813875 | Eltrombopag Olamine |
| 2010-700197 (■) | 3813875 | Eltrombopag Olamine |
| 2010-700196 (○) | 3259768 | Human L-type fatty acid binding protein (L-FABP) kit |
| 2010-700196 (■) | 3259768 | Renapro L-FABP test (human L-type fatty acid binding protein |
| 2010-700195 (○) | 4395642 | Container for inhalation (container for inhalation of Laninamivir octanoate hydrate) |
| 2010-700194 (○) | 4424644 | Laninamivir octanoate ester hydrate |
| 2010-700194 (■) | 4424644 | Laninamivir octanoate ester hydrate |
| 2010-700193 (○) | 3920041 | Laninamivir octanoate ester hydrate |
| 2010-700193 (■) | 3920041 | Laninamivir octanoate ester hydrate |
| 2010-700192 (○) | 3233392 | Laninamivir octanoate ester hydrate |
| 2010-700192 (■) | 3233392 | Laninamivir octanoate ester hydrate |
| 2010-700191 (○) | 3209946 | Laninamivir octanoate ester hydrate |
| 2010-700191 (■) | 3209946 | Laninamivir octanoate ester hydrate |
| 2010-700190 (○) | 3895349 | Alogliptin benzoate (brand name: Nesina Tablets 25 mg) |
| 2010-700190 (■) | 3895349 | Alogliptin benzoate (brand name: Nesina Tablets 25 mg) |
| 2010-700189 (○) | 3895349 | Alogliptin benzoate (brand name: Nesina tablet 12.5 mg) |
| 2010-700189 (■) | 3895349 | Alogliptin benzoate (brand name: Nesina tablet 12.5 mg) |
| 2010-700188 (○) | 3895349 | Alogliptin benzoate (brand name: Nesina Tablet 6.25 mg) |
| 2010-700188 (■) | 3895349 | Alogliptin benzoate (brand name: Nesina Tablet 6.25 mg) |
| 2010-700187 (○) | 4481828 | Lebramide capsule 5 mg (lenalidomide hydrate) |
| 2010-700187 (■) | 4481828 | Lenalidomide hydrate |
| 2010-700186 (○) | 4065567 | Lebramide capsule 5 mg (lenalidomide hydrate) |
| 2010-700186 (■) | 4065567 | Lenalidomide hydrate |
| 2010-700185 (○) | 4445791 | Takepron OD Tablet 15 (Lansoprazole) |
| 2010-700185 (■) | 4445791 | Takepron OD Tablet 15 (Lansoprazole) |
| 2010-700184 (○) | 3404648 | Takepron OD Tablet 15 (Lansoprazole) |
| 2010-700184 (■) | 3404648 | Takepron OD Tablet 15 (Lansoprazole) |
| 2010-700183 (○) | 3746167 | Takepron OD Tablet 15 (Lansoprazole) |
| 2010-700183 (■) | 3746167 | Takepron OD Tablet 15 (Lansoprazole) |
| 2010-700182 (○) | 4444908 | Takepron OD Tablet 15 (Lansoprazole) |
| 2010-700182 (■) | 4444908 | Takepron OD Tablet 15 (Lansoprazole) |
| 2010-700181 (○) | 4444908 | Takepron Capsule 15 (Lansoprazole) |
| 2010-700181 (■) | 4444908 | Takepron Capsule 15 (Lansoprazole) |
| 2010-700180 (○) | 3828648 | Takepron OD Tablet 15 (Lansoprazole) |
| 2010-700180 (■) | 3828648 | Takepron OD Tablet 15 (Lansoprazole) |
| 2010-700179 (○) | 3828648 | Takepron Capsule 15 (Lansoprazole) |
| 2010-700179 (■) | 3828648 | Takepron Capsule 15 (Lansoprazole) |
| 2010-700178 (○) | 3933689 | (Sale name) Selmune N |
| 2010-700178 (■) | 3933689 | Newcastle disease virus derived F protein transgenic Marek's disease virus type I strain 207 |
| 2010-700177 (○) | 3428666 | (Sale name) Selmune N |
| 2010-700177 (■) | 3428666 | Newcastle disease virus derived F protein transgenic Marek's disease virus type I strain 207 |
| 2010-700176 (○) | 3000240 | Methyl = (E) -methoxyimino-{(E) -α- [1- (α, α, α-trifluoro-m-tolyl) ethylideneaminooxy] -o-tolyl acetate |
| 2010-700176 (■) | 3000240 | Methyl = (E) -methoxyimino-{(E) -α- [1- (α, α, α-trifluoro-m-tolyl) ethylideneaminooxy] -o-tolyl acetate |
| 2010-700175 (○) | 4227649 | Tolycel Intravenous Solution 25 mg |
| 2010-700174 (○) | 3725901 | Tolycel Intravenous Solution 25 mg |
| 2010-700174 (■) | 3725901 | Temsirolimus |
| 2010-700173 (○) | 2709225 | Micamuro combination tablet AP |
| 2010-700172 (○) | 4354667 | Yazd tablet (active ingredient: drospirenone and ethynyl estradiol betadex) |
| 2010-700172 (■) | 4354667 | Yazd tablet (active ingredient: drospirenone and ethynyl estradiol betadex) |
| 2010-700171 (○) | 3746293 | Abraxane Intravenous Injection 100mg General name: paclitaxel |
| 2010-700171 (■) | 3746293 | Abraxane Intravenous Injection 100mg General name: paclitaxel |
| 2010-700170 (○) | 4445791 | Takepron OD Tablet 15 (Lansoprazole) |
| 2010-700170 (■) | 4445791 | Takepron OD Tablet 15 (Lansoprazole) |
| 2010-700169 (○) | 3404648 | Takepron OD Tablet 15 (Lansoprazole) |
| 2010-700169 (■) | 3404648 | Takepron OD Tablet 15 (Lansoprazole) |
| 2010-700168 (○) | 3746167 | Takepron OD Tablet 15 (Lansoprazole) |
| 2010-700168 (■) | 3746167 | Takepron OD Tablet 15 (Lansoprazole) |
| 2010-700167 (■) | 4444908 | Takepron OD Tablet 15 (Lansoprazole) |
| 2010-700166 (○) | 4444908 | Takepron Capsule 15 (Lansoprazole) |
| 2010-700166 (■) | 4444908 | Takepron Capsule 15 (Lansoprazole) |
| 2010-700165 (○) | 3828648 | Takepron OD Tablet 15 (Lansoprazole) |
| 2010-700165 (■) | 3828648 | Takepron OD Tablet 15 (Lansoprazole) |
| 2010-700164 (○) | 3828648 | Takepron Capsule 15 (Lansoprazole) |
| 2010-700164 (■) | 3828648 | Takepron Capsule 15 (Lansoprazole) |
| 2010-700163 (○) | 2140632 | Name of sale: Cybis Kudso joint injection 2mL Common name: Sodium hyaluronate cross-linked polymer and sodium hyaluronate cross-linked polymer vinyl sulfonic acid cross-linked product |
| 2010-700162 (○) | 3722375 | Abatacept (genetically modified) |
| 2010-700162 (■) | 3722375 | Abatacept (genetically modified) |
| 2010-700161 (○) | 4093611 | Bazedoxifene acetate (brand name: Viviant tablets 20 mg) |
| 2010-700161 (■) | 4093611 | Bazedoxifene acetate (brand name: Viviant tablets 20 mg) |
| 2010-700160 (○) | 3957748 | Common Name: Ambrisentan |
| 2010-700160 (■) | 3957748 | Common Name: Ambrisentan |
| 2010-700159 (○) | 4001622 | Common Name: Ambrisentan |
| 2010-700159 (■) | 4001622 | Common Name: Ambrisentan |
| 2010-700158 (○) | 4512105 | Common Name: Ambrisentan |
| 2010-700158 (■) | 4512105 | Common Name: Ambrisentan |
| 2010-700157 (○) | 4065567 | Lebramide capsule 5 mg (lenalidomide hydrate) |
| 2010-700157 (■) | 4065567 | Lenalidomide hydrate |
| 2010-700156 (○) | 3068033 | (A) Drugs subject to disposal (brand name) Epogin hypodermic syringe 24000 b) Active ingredients of medications subject to disposal (general name) epoetin beta (genetic recombination ) |
| 2010-700155 (○) | 2709225 | Micardis Tablets 80 mg Active Ingredient: Telmisartan |
| 2010-700154 (○) | 4456177 | 20 mg for teralubicin injection (General name: pirarubicin) |
| 2010-700154 (■) | 4456177 | 20 mg of teralubicin for injection common name: pirarubicin |
| 2010-700153 (○) | 4456177 | 10mg for teralubicin injection (General name: pirarubicin) |
| 2010-700153 (■) | 4456177 | 10 mg of teralubicin for injection Common name: pirarubicin |
| 2010-700152 (○) | 4405666 | Stabilized teriparatide solution |
| 2010-700152 (■) | 4405666 | Teriparatide (genetically modified) |
| 2010-700151 (○) | 4088036 | 3,4-Dichloro-2'-cyano-1,2-thiazole-5-carboxanilide |
| 2010-700151 (■) | 4088036 | 3,4-Dichloro-2'-cyano-1,2-thiazole-5-carboxanilide |
| 2010-700150 (○) | 4088036 | 3,4-Dichloro-2'-cyano-1,2-thiazole-5-carboxanilide |
| 2010-700150 (■) | 4088036 | 3,4-Dichloro-2'-cyano-1,2-thiazole-5-carboxanilide |
| 2010-700149 (○) | 4088036 | 3,4-Dichloro-2'-cyano-1,2-thiazole-5-carboxanilide |
| 2010-700149 (■) | 4088036 | 3,4-Dichloro-2'-cyano-1,2-thiazole-5-carboxanilide |
| 2010-700148 (■) | 4088036 | 3,4-Dichloro-2'-cyano-1,2-thiazole-5-carboxanilide |
| 2010-700147 (○) | 4088036 | 3,4-Dichloro-2'-cyano-1,2-thiazole-5-carboxanilide |
| 2010-700147 (■) | 4088036 | 3,4-Dichloro-2'-cyano-1,2-thiazole-5-carboxanilide |
| 2010-700146 (■) | 3993768 | Active ingredient: Olopatadine hydrochloride (Product Name: Allelock OD tablet 2.5 Allelock OD tablet 2.5 is an orally disintegrating tablet containing 2.5 mg of olopatadine hydrochloride in one tablet It is a tablet manufactured using an agent spray type tableting machine. |
| 2010-700145 (○) | 3993768 | Name of sale: Allelock OD Tablet 5 AlleLock OD Tablet 5 is a tablet manufactured using a lubricant spray type tableting machine, containing 5 mg of olopatadine hydrochloride in one tablet. |
| 2010-700145 (■) | 3993768 | Active ingredient: Olopatadine hydrochloride Sales name: Alleloc OD Tablet 5 Alerok OD Tablet 5 is an orally disintegrating tablet containing 5 mg of Olopatadine hydrochloride in one tablet, and is a lubricant spray type tableting tablet. It is a tablet manufactured using a machine. |
| 2010-700144 (○) | 3983476 | Name of sale: Allelock OD Tablet 2.5 AlleLock OD Tablet 2.5 is a tablet manufactured using a lubricant spray type tableting machine, containing 2.5 mg of olopatadine hydrochloride in one tablet. is there. |
| 2010-700144 (■) | 3983476 | Active ingredient: Olopatadine hydrochloride (Product Name: Allelock OD tablet 2.5 Allelock OD tablet 2.5 is an orally disintegrating tablet containing 2.5 mg of olopatadine hydrochloride in one tablet It is a tablet manufactured using an agent spray type tableting machine. |
| 2010-700142 (○) | 3797387 | Name of sale: Allelock OD Tablet 2.5 AlleLock OD Tablet 2.5 is an orally disintegrating tablet containing 2.5 mg of olopatadine hydrochloride in one tablet. |
| 2010-700142 (■) | 3797387 | Active ingredient: Olopatadine hydrochloride Sales name: Allelock OD tablet 2.5 Allelock OD tablet 2.5 is an orally disintegrating tablet containing 2.5 mg of olopatadine hydrochloride in one tablet. |
| 2010-700141 (○) | 3797387 | Name of sale: Allelock OD Tablet 5 AlleLock OD Tablet 5 is an orally disintegrating tablet containing 5 mg of olopatadine hydrochloride in one tablet. |
| 2010-700141 (■) | 3797387 | Active ingredient: Olopatadine hydrochloride Sales name: Allelock OD tablet 5 Allelock OD tablet 5 is an orally disintegrating tablet containing 5 mg of olopatadine hydrochloride in one tablet. |
| 2010-700140 (○) | 3499097 | Types of Pesticide: Lepimectin Emulsion Pesticide Name: Aniki Emulsion |
| 2010-700140 (■) | 3499097 | Types of Pesticide: Lepimectin Emulsion Pesticide Name: Aniki Emulsion |
| 2010-700139 (○) | 3499097 | Types of Pesticides: Lepimectin Wettable Powder Name of Pesticides: Anikiflowable |
| 2010-700139 (■) | 3499097 | Types of Pesticides: Lepimectin Wettable Powder Name of Pesticides: Anikiflowable |
| 2010-700138 (○) | 4195178 | Loxonin gel 1% |
| 2010-700138 (■) | 4195178 | Name of sale: Loxonin gel 1% Active ingredient/General name: Loxoprofen sodium hydrate |
| 2010-700137 (○) | 3856816 | Pregabalin (general name) |
| 2010-700137 (■) | 3856816 | Pregabalin (general name) |
| 2010-700136 (○) | 3856816 | Pregabalin (general name) |
| 2010-700136 (■) | 3856816 | Pregabalin (general name) |
| 2010-700135 (○) | 3856816 | Pregabalin (general name) |
| 2010-700135 (■) | 3856816 | Pregabalin (general name) |
| 2010-700134 (○) | 3757986 | Name of Sale: Vectibix Intravenous Drip Injection 100 mg Common Name: Panitumumab (genetically modified) |
| 2010-700134 (■) | 3757986 | Name of Sale: Vectibix Intravenous Drip Injection 100 mg Common Name: Panitumumab (genetically modified) |
| 2010-700133 (○) | 3650258 | Name of sale: Duo Trava combination eye drops |
| 2010-700133 (■) | 3650258 | Common Names: Travoprost and Timolol Maleate |
| 2010-700132 (○) | 2938572 | Darbepoetin alpha (genetically modified) |
| 2010-700132 (■) | 2938572 | Darbepoetin alpha (genetically modified) |
| 2010-700131 (○) | 3073905 | Darbepoetin alpha (genetically modified) |
| 2010-700131 (■) | 3073905 | Darbepoetin alpha (genetically modified) |
| 2010-700130 (○) | 4236553 | Mekact combination tablet HD (combination drug of pioglitazone hydrochloride and metformin hydrochloride) |
| 2010-700130 (■) | 4236553 | Name of sale: Metacto combination tablet HD, Active ingredient: pioglitazone hydrochloride and metformin hydrochloride |
| 2010-700129 (○) | 4236553 | Mekact combination tablet LD (combination drug of pioglitazone hydrochloride and metformin hydrochloride) |
| 2010-700129 (■) | 4236553 | Name of sale: Mekact combination tablets LD, Active ingredient: pioglitazone hydrochloride and metformin hydrochloride |
| 2010-700128 (○) | 3973280 | Mekact combination tablet HD (combination drug of pioglitazone hydrochloride and metformin hydrochloride) |
| 2010-700128 (■) | 3973280 | Pioglitazone hydrochloride / metformin hydrochloride (Metact combination tablet HD) |
| 2010-700127 (○) | 3973280 | Mekact combination tablet LD (combination drug of pioglitazone hydrochloride and metformin hydrochloride) |
| 2010-700127 (■) | 3973280 | Pioglitazone hydrochloride / metformin hydrochloride (Metact combination tablet LD) |
| 2010-700126 (○) | 3256841 | Metacto combination tablet HD (combination drug of pioglitazone hydrochloride and metformin hydrochloride, pioglitazone hydrochloride to be combined with metformin hydrochloride) |
| 2010-700125 (○) | 3256841 | Megacto combination tablet LD (combination drug of pioglitazone hydrochloride and metformin hydrochloride, pioglitazone hydrochloride compounded with metformin hydrochloride) |
| 2010-700124 (○) | 3633895 | Ramelteon |
| 2010-700124 (■) | 3633895 | Roserem Tablets 8 mg Ramelteon as active ingredient |
| 2010-700123 (○) | 2884153 | Ramelteon |
| 2010-700123 (■) | 2884153 | Ramelteon |
| 2010-700122 (○) | 4003008 | Diquas eye drop 3% (active ingredient diquafosol sodium) |
| 2010-700121 (○) | 3652707 | Diquas eye drop 3% (active ingredient diquafosol sodium) |
| 2010-700121 (■) | 3652707 | Diquas eye drop 3% (active ingredient diquafosol sodium) |
| 2010-700120 (○) | 3723227 | Diquas eye drop 3% (active ingredient diquafosol sodium) |
| 2010-700120 (■) | 3723227 | Diquas eye drop 3% (active ingredient diquafosol sodium) |
| 2010-700119 (○) | 3734266 | Common name: eculizumab (genetically modified) |
| 2010-700119 (■) | 3734266 | Common name: eculizumab (genetically modified) |
| 2010-700118 (○) | 2853611 | Unisia combination tablet HD (combination drug of candesartan cilexetil and amlodipine besylate, candesartan cilexetil combined with amlodipine besylate) |
| 2010-700118 (■) | 2853611 | Candesartan cilexetil · amlodipine besylate (Unisia formulated tablet LD) |
| 2010-700117 (○) | 2853611 | Unisia combination tablet LD (combination drug of candesartan cilexetil and amlodipine besylate, candesartan cilexetil combined with amlodipine besylate) |
| 2010-700117 (■) | 2853611 | Candesartan cilexetil · amlodipine besylate (Unisia formulated tablet LD) |
| 2010-700116 (○) | 2730501 | Unisia combination tablet HD (combination drug of candesartan cilexetil and amlodipine besylate, candesartan cilexetil combined with amlodipine besylate) |
| 2010-700116 (■) | 2730501 | Candesartan cilexetil · amlodipine besylate (Unisia formulated tablet LD) |
| 2010-700115 (○) | 2730501 | Unisia combination tablet LD (combination drug of candesartan cilexetil and amlodipine besylate, candesartan cilexetil combined with amlodipine besylate) |
| 2010-700115 (■) | 2730501 | Candesartan cilexetil · amlodipine besylate (Unisia formulated tablet LD) |
| 2010-700114 (○) | 3057471 | Unisia combination tablet HD (combination drug of candesartan cilexetil and amlodipine besylate) |
| 2010-700114 (■) | 3057471 | Candesartan cilexetil amlodipine besylate (Uniscia combination tablet HD) |
| 2010-700113 (○) | 3057471 | Unisia combination tablet LD (combination drug of can desartan cilexetil and amlodipine besylate) |
| 2010-700113 (■) | 3057471 | Candesartan cilexetil · amlodipine besylate (Unisia formulated tablet LD) |
| 2010-700112 (○) | 2682353 | Unisia combination tablet HD (combination drug of candesartan cilexetil and amlodipine besylate, candesartan cilexetil combined with amlodipine besylate) |
| 2010-700112 (■) | 2682353 | Candesartan cilexetil · amlodipine besylate (Unisia formulated tablet LD) |
| 2010-700111 (○) | 2682353 | Unisia combination tablet LD (combination drug of candesartan cilexetil and amlodipine besylate, candesartan cilexetil combined with amlodipine besylate) |
| 2010-700111 (■) | 2682353 | Candesartan cilexetil · amlodipine besylate (Unisia formulated tablet LD) |
| 2010-700110 (○) | 2514282 | Unisia combination tablet HD (combination drug of candesartan cilexetil and amlodipine besylate, candesartan cilexetil combined with amlodipine besylate) |
| 2010-700110 (■) | 2514282 | Candesartan cilexetil · amlodipine besylate (Unisia formulated tablet LD) |
| 2010-700109 (○) | 2514282 | Unisia combination tablet LD (combination drug of candesartan cilexetil and amlodipine besylate, candesartan cilexetil combined with amlodipine besylate) |
| 2010-700109 (■) | 2514282 | Candesartan cilexetil · amlodipine besylate (Unisia formulated tablet LD) |
| 2010-700108 (○) | 2527513 | Common Name: Dorzolamide Hydrochloride / Timolol Maleate |
| 2010-700108 (■) | 2527513 | Name of sale: KOSOPT ophthalmic solution Active ingredient: dorzolamide hydrochloride and timolol maleate |
| 2010-700107 (○) | 3693258 | Pregabalin (brand name: Lyrica Capsule 150 mg) |
| 2010-700107 (■) | 3693258 | Pregabalin (brand name: Lyrica Capsule 150 mg) |
| 2010-700106 (○) | 3693258 | Pregabalin (brand name: Lilyca Capsule 75 mg) |
| 2010-700106 (■) | 3693258 | Pregabalin (brand name: Lilyca Capsule 75 mg) |
| 2010-700105 (○) | 3693258 | Pregabalin (brand name: Lyrica Capsule 25 mg) |
| 2010-700105 (■) | 3693258 | Pregabalin (brand name: Lyrica Capsule 25 mg) |
| 2010-700104 (○) | 3895349 | Alogliptin benzoate (brand name: Nesina Tablets 25 mg) |
| 2010-700104 (■) | 3895349 | Alogliptin benzoate (brand name: Nesina Tablets 25 mg) |
| 2010-700103 (○) | 3895349 | Alogliptin benzoate (brand name: Nesina tablet 12.5 mg) |
| 2010-700103 (■) | 3895349 | Alogliptin benzoate (brand name: Nesina tablet 12.5 mg) |
| 2010-700102 (○) | 3895349 | Alogliptin benzoate (brand name: Nesina Tablet 6.25 mg) |
| 2010-700102 (■) | 3895349 | Alogliptin benzoate (brand name: Nesina Tablet 6.25 mg) |
| 2010-700101 (○) | 2994182 | Flonicamid |
| 2010-700101 (■) | 2994182 | Flonicamid |
| 2010-700100 (○) | 4227418 | Types of Pesticides: Tefuryltrione / mefenaset Granule Pesticide Name: Possible Jumbo Active Ingredient General Name, Chemical Name and Content: Common Name: Tefuryl Trione Chemical Name : 2- {2-chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione content: 6.0%, and > General name: Mefenacet Chemical name: 2-benzothiazol-2-yloxy-N-methylacetanilide content: 20.0% |
| 2010-700100 (■) | 4227418 | Types of Pesticides: Tefuryltrione / mefenaset Granule Pesticide Name: Possible Jumbo Active Ingredient General Name, Chemical Name and Content: Common Name: Tefuryl Trione Chemical Name : 2- {2-chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione content: 6.0%, and > General name: Mefenacet Chemical name: 2-benzothiazol-2-yloxy-N-methylacetanilide content: 20.0% |
| 2010-700099 (○) | 4227418 | Types of pesticides: tefuryl trione, mefenaset water dispersible powder Name of pesticides: possible flowable active ingredient name, chemical name and content: General name: tefuryl trione chemistry Name: 2- {2-chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione content: 5.5%, and common name: mefenaset chemical name: 2-benzothiazol-2-yloxy-N-methylacetanilide content: 18.3% |
| 2010-700099 (■) | 4227418 | Types of pesticides: tefuryl trione, mefenaset water dispersible powder Name of pesticides: possible flowable active ingredient name, chemical name and content: General name: tefuryl trione chemistry Name: 2- {2-chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione content: 5.5%, and common name: mefenaset chemical name: 2-benzothiazol-2-yloxy-N-methylacetanilide content: 18.3% |
| 2010-700098 (○) | 4227418 | Types of pesticides: tefuryltrione mefenaset granules name of pesticide: 1 kg granules possible common name of active ingredient, chemical name and content: General name: tefuryltrione Chemical name: 2- {2-chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione content: 3.0%, and , General name: mefenaset chemical name: 2-benzothiazol-2-yloxy-N-methylacetanilide content: 12.0% |
| 2010-700098 (■) | 4227418 | Types of pesticides: tefuryltrione mefenaset granules name of pesticide: 1 kg granules possible common name of active ingredient, chemical name and content: General name: tefuryltrione Chemical name: 2- {2-chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione content: 3.0%, and , General name: mefenaset chemical name: 2-benzothiazol-2-yloxy-N-methylacetanilide content: 12.0% |
| 2010-700097 (○) | 2960039 | Enbrel subcutaneous injection 50 mg syringe 1.0 ml |
| 2010-700096 (○) | 3550410 | Histamine Release Test Kit-Product Name: Arapport HRT Lysozyme |
| 2010-700096 (■) | 3550410 | Histamine Release Test Kit (trade name: Arapport HRT Lysozyme) The components involved in the reaction system are as follows. i) lysozyme allergen ii) mouse anti-human leukocyte monoclonal antibody conjugated magnetic beads name of monoclonal antibody producing cell: mouse hybridoma BA312 iii) peroxidase (HRP) labeled mouse antihistamine monoclonal antibody < br> Name of monoclonal antibody-producing cell: mouse hybridoma HD2-14 iv) biotinylated histamine v) rabbit anti-biotin polyclonal antibody conjugated magnetic beads vi) 3,3'5,5'_ Tetramethyl benzidine vii) hydrogen peroxide water (30%) |
| 2010-700095 (○) | 3550410 | Histamine Release Test Kit-Product Name: Arapport HRT Ovalbumin) |
| 2010-700095 (■) | 3550410 | Histamine Release Test Kit (trade name: Arapport HRT ovalbumin) The components involved in the reaction system are as follows. i) ovalbumin allergen ii) mouse anti-human leukocyte monoclonal antibody conjugated magnetic beads name of monoclonal antibody producing cell: mouse hybridoma BA312 iii) peroxidase (HRP) labeled mouse antihistamine monoclonal antibody Names of monoclonal antibody-producing cells: mouse hybridoma HD2-14 iv) biotinylated histamine v) rabbit anti-biotin polyclonal antibody conjugated magnetic beads vi) 3, 3 ', 5, 5' _ Tetramethyl benzidine vii) hydrogen peroxide solution (30%) |
| 2010-700094 (○) | 3550410 | Histamine Release Test Kit Sale name: Arapport HRT human sweat) |
| 2010-700094 (■) | 3550410 | Histamine Release Test Kit (brand name: Arapport HRT human sweat) The components involved in the reaction system are as follows. i) Human sweat allergen ii) Mouse anti-human leukocyte monoclonal antibody conjugated magnetic beads Name of monoclonal antibody producing cell: Mouse hybridoma BA 312 iii) Peroxidase (HRP) labeled mouse antihistamine monoclonal antibody Names of monoclonal antibody-producing cells: mouse hybridoma HD2-14 iv) biotinylated histamine v) rabbit anti-biotin polyclonal antibody conjugated magnetic beads vi) 3, 3 ', 5, 5' _ Tetramethyl benzidine vii) hydrogen peroxide solution (30%) |
| 2010-700091 (○) | 4243349 | General name: Emulsion cell culture influenza A HA vaccine (H1N1 strain) |
| 2010-700090 (○) | 4243349 | General name: Emulsion cell culture influenza A HA vaccine (H1N1 strain) |
| 2010-700089 (○) | 4077794 | Name of sale: Temodar 100 mg for intravenous infusion General name: Temozolomide |
| 2010-700089 (■) | 4077794 | Name of sale: Temodar 100 mg for intravenous infusion General name: Temozolomide |
| 2010-700088 (○) | 1995302 | Spiriba 2.5 μg Respimat 60 Inhaled Active Ingredient: Tiotropium Bromide Hydrate |
| 2010-700087 (○) | 4344135 | Spiriba 2.5 μg Respimat 60 Inhaled Active Ingredient: Tiotropium Bromide Hydrate |
| 2010-700087 (■) | 4344135 | Spiriba 2.5 μg Respimat 60 Inhaled Active Ingredient: Tiotropium Bromide Hydrate |
| 2010-700086 (○) | 4406685 | Bi-Sifrolet Tablet 0.125mg Active Ingredient: Pramipexole Hydrochloride Hydrate |
| 2010-700086 (■) | 4406685 | Pramipexole Hydrochloride Hydrate (Brand name: Bi Sifrole Tablets 0.125 mg) |
| 2010-700085 (○) | 4406685 | Bi-Sifrolet Tablets 0.5mg Active Ingredient: Pramipexole Hydrochloride Hydrate |
| 2010-700085 (■) | 4406685 | Pramipexole Hydrochloride Hydrate (Trade Name: Bi Sifrole Tablets 0.5 mg) |
| 2010-700084 (○) | 3874419 | Active ingredient name: Olmesartan medoxomil and azelnidipine |
| 2010-700084 (■) | 3874419 | Active ingredient name: Olmesartan medoxomil and azelnidipine |
| 2010-700083 (○) | 3874419 | Active ingredient name: Olmesartan medoxomil and azelnidipine |
| 2010-700082 (○) | 2082519 | Active ingredient name: Olmesartan medoxomil and azelnidipine |
| 2010-700082 (■) | 2082519 | Active ingredient name: Olmesartan medoxomil and azelnidipine |
| 2010-700081 (○) | 2082519 | Active ingredient name: Olmesartan medoxomil and azelnidipine |
| 2010-700081 (■) | 2082519 | Active ingredient name: Olmesartan medoxomil and azelnidipine |
| 2010-700080 (○) | 3880041 | Common name: Sugamadex sodium |
| 2010-700080 (■) | 3880041 | Common name: Sugamadex sodium |
| 2010-700079 (○) | 3880041 | Common name: Sugamadex sodium |
| 2010-700079 (■) | 3880041 | Common name: Sugamadex sodium |
| 2010-700078 (○) | 3729825 | Active ingredient (chemical name): 3-bromo-N- [4-chloro-2-methyl-6- (methylcarbamoyl) phenyl] -1- (3-chloropyridin-2-yl) -1H-pyrazole-5- Carboxamide 3- (2-chloro-1,3-thiazol-5-ylmethyl) -5-methyl-1,3,5-oxadiazinan-4-ylidene (nitro) amine |
| 2010-700078 (■) | 3729825 | Types of pesticides: chlorantranilipurol thiamethoxam wettable powder Name of pesticide: Duribo flowable Active ingredient (chemical name): 3-bromo-N- [4-chloro-2-methyl-6 -(Methylcarbamoyl) phenyl] -1- (3-chloropyridin-2-yl) -1H-pyrazole-5-carboxamide 3- (2-chloro-1,3-thiazol-5-ylmethyl) -5-methyl- 1,3,5-oxadiazinan-4-ylidene (nitro) amine |
| 2010-700077 (○) | 3707831 | Duloxetine hydrochloride |
| 2010-700077 (■) | 3707831 | Product Name: Cyvarta Capsule 30 mg Common Name: Duloxetine Hydrochloride Chemical Name: (+)-(S) -N-Methyl-3- (1-naphthyloxy) -3- (2-thienyl) propylamine monohydrochloride |
| 2010-700076 (○) | 3707831 | Duloxetine hydrochloride |
| 2010-700076 (■) | 3707831 | Sales name: Cyvarta capsule 20 mg General name: duloxetine hydrochloride Chemical name: (+)-(S) -N-methyl-3- (1-naphthyloxy) -3- (2-thienyl) ) Propylamine monohydrochloride |
| 2010-700075 (○) | 3117462 | Name: Afinitor Tablet 5mg Common Name: Everolimus |
| 2010-700075 (■) | 3117462 | Name: Afinitor Tablet 5mg Common Name: Everolimus |
| 2010-700074 (○) | 3987130 | Cyazofamid |
| 2010-700074 (■) | 3987130 | Cyazofamid |
| 2010-700073 (○) | 2749458 | Name of sale: X Forge combination tablet Common name: Valsartan and Amlodipine |
| 2010-700073 (■) | 2749458 | Name of sale: X Forge combination tablet Common name: Valsartan and Amlodipine |
| 2010-700072 (○) | 1935956 | Name: Alloxy IV 0.75mg Common Name: Palonosetron Hydrochloride |
| 2010-700072 (■) | 1935956 | Name: Alloxy IV 0.75mg Common Name: Palonosetron Hydrochloride |
| 2010-700071 (○) | 4102022 | Peramivir hydrate adalimumab (genetically modified) |
| 2010-700071 (■) | 4102022 | Peramivir hydrate |
| 2010-700070 (○) | 4102022 | Peramivir hydrate adalimumab (genetically modified) |
| 2010-700070 (■) | 4102022 | Peramivir hydrate |
| 2010-700069 (○) | 4262920 | Peramivir hydrate adalimumab (genetically modified) |
| 2010-700069 (■) | 4262920 | Peramivir hydrate |
| 2010-700068 (○) | 4262920 | Peramivir hydrate |
| 2010-700068 (■) | 4262920 | Peramivir hydrate |
| 2010-700067 (○) | 3681110 | Name of sale: Equa Tablet 50 mg General name: vildagliptin |
| 2010-700067 (■) | 3681110 | Name of sale: Equa Tablet 50 mg General name: vildagliptin |
| 2010-700066 (○) | 4404181 | Adalimumab (genetically modified) |
| 2010-700066 (■) | 4404181 | Adalimumab (genetically modified) |
| 2010-700065 (○) | 3861118 | Adalimumab (genetically modified) |
| 2010-700065 (■) | 3861118 | Adalimumab (genetically modified) |
| 2010-700064 (○) | 4139325 | Jill Rotapide (brand name: Srent Roll) |
| 2010-700064 (■) | 4139325 | Jill Rotapide (brand name: Srent Roll) |
| 2010-700063 (○) | 3149958 | Liraglutide (genetically modified) |
| 2010-700063 (■) | 3149958 | Liraglutide (genetically modified) |
| 2010-700062 (○) | 4064965 | Name of sale: Reno coat powder spray for nose 25μg name of active ingredient beclomethasone propionate ester |
| 2010-700061 (○) | 4020589 | Name of sale: Reno coat powder spray for nose 25μg name of active ingredient beclomethasone propionate ester |
| 2010-700060 (○) | 3960916 | Name of sale: Reno coat powder spray for nose 25μg name of active ingredient beclomethasone propionate ester |
| 2010-700059 (○) | 2021429 | Chemical name: O-ethyl = S-propyl = (E)-[2- (cyanoimino) -3-ethylimidazolidin-1-yl] phosphonothioate |
| 2010-700059 (■) | 2021429 | Chemical name: O-ethyl = S-propyl = (E)-[2- (cyanoimino) -3-ethylimidazolidin-1-yl] phosphonothioate |
| 2010-700058 (○) | 3622983 | I) General name: oseltamivir phosphate ii) Sales name: Tamiflu capsule 75 |
| 2010-700057 (○) | 3622983 | I) General name: oseltamivir phosphate ii) Name: Tamiflu dry syrup 3% |
| 2010-700056 (○) | 3300365 | I) General name: oseltamivir phosphate ii) Sales name: Tamiflu capsule 75 |
| 2010-700055 (○) | 3300365 | I) General name: oseltamivir phosphate ii) Name: Tamiflu dry syrup 3% |
| 2010-700054 (○) | 3455782 | Common Name: Anti-RNA Polymerase III Antibody Kit (84049000) (Product Name: MESACUP anti-RNA Polymerase III Test) |
| 2010-700053 (○) | 3502342 | I) General name: oseltamivir phosphate ii) Name: Tamiflu dry syrup 3% |
| 2010-700052 (○) | 3502342 | I) General name: oseltamivir phosphate ii) Sales name: Tamiflu capsule 75 |
| 2010-700051 (○) | 2994182 | Flonicamid |
| 2010-700051 (■) | 2994182 | Flonicamid |
| 2010-700050 (○) | 3957765 | Bevacizumab (genetically modified) |
| 2010-700050 (■) | 3957765 | Bevacizumab (genetically modified) |
| 2010-700049 (○) | 3957765 | Bevacizumab (genetically modified) |
| 2010-700049 (■) | 3957765 | Bevacizumab (genetically modified) |
| 2010-700048 (○) | 3398382 | Bevacizumab (genetically modified) |
| 2010-700048 (■) | 3398382 | Bevacizumab (genetically modified) |
| 2010-700047 (○) | 3398382 | Bevacizumab (genetically modified) |
| 2010-700047 (■) | 3398382 | Bevacizumab (genetically modified) |
| 2010-700046 (○) | 3523870 | Fludarabine phosphate ester |
| 2010-700045 (○) | 3202234 | Fludarabine phosphate ester |
| 2010-700044 (○) | 4261051 | Fludarabine phosphate ester |
| 2010-700043 (○) | 3523870 | Fludarabine phosphate ester |
| 2010-700042 (○) | 3202234 | Fludarabine phosphate ester |
| 2010-700041 (○) | 4261051 | Fludarabine phosphate ester |
| 2010-700040 (○) | 3986085 | General name: ethiprole Chemical name: 5-amino-1- (2,6-dichloro-α, α, α-trifluoro-p-tolyl) -4-ethylsulfinylpyrazole-3-carbonitrile |
| 2010-700040 (■) | 3986085 | General name: ethiprole Chemical name: 5-amino-1- (2,6-dichloro-α, α, α-trifluoro-p-tolyl) -4-ethylsulfinylpyrazole-3-carbonitrile |
| 2010-700039 (○) | 3000240 | Methyl = (E) -methoxyimino-{(E) -α- [1- (α, α, α-trifluoro-m-tolyl) ethylideneaminooxy] -o-tolyl acetate |
| 2010-700039 (■) | 3000240 | Methyl = (E) -methoxyimino-{(E) -α- [1- (α, α, α-trifluoro-m-tolyl) ethylideneaminooxy] -o-tolyl acetate |
| 2010-700038 (○) | 2082519 | Active ingredient name: Olmesartan Medoxomil |
| 2010-700037 (○) | 4028593 | Serverix |
| 2010-700036 (○) | 4236698 | Nonacog alpha (genetically modified) |
| 2010-700036 (■) | 4236698 | Nonacog alpha (genetically modified) |
| 2010-700035 (○) | 4236698 | Nonacog alpha (genetically modified) |
| 2010-700035 (■) | 4236698 | Nonacog alpha (genetically modified) |
| 2010-700034 (○) | 4236698 | Nonacog alpha (genetically modified) |
| 2010-700034 (■) | 4236698 | Nonacog alpha (genetically modified) |
| 2010-700033 (○) | 4236698 | Nonacog alpha (genetically modified) |
| 2010-700033 (■) | 4236698 | Nonacog alpha (genetically modified) |
| 2010-700032 (○) | 3676817 | Nonacog alpha (genetically modified) |
| 2010-700032 (■) | 3676817 | Nonacog alpha (genetically modified) |
| 2010-700031 (○) | 3676817 | Nonacog alpha (genetically modified) |
| 2010-700031 (■) | 3676817 | Nonacog alpha (genetically modified) |
| 2010-700030 (○) | 3676817 | Nonacog alpha (genetically modified) |
| 2010-700030 (■) | 3676817 | Nonacog alpha (genetically modified) |
| 2010-700029 (○) | 3676817 | Nonacog alpha (genetically modified) |
| 2010-700029 (■) | 3676817 | Nonacog alpha (genetically modified) |
| 2010-700028 (○) | 4144813 | Precipitated 7-valent pneumococcal conjugate vaccine (nontoxic mutant diphtheria toxin conjugate) |
| 2010-700027 (○) | 4272991 | Miriplatin hydrate |
| 2010-700027 (■) | 4272991 | Miriplatin hydrate |
| 2010-700026 (○) | 3007630 | Miriplatin hydrate |
| 2010-700026 (■) | 3007630 | Miriplatin hydrate |
| 2010-700025 (○) | 2886247 | Miriplatin hydrate |
| 2010-700024 (○) | 2950775 | 7.5mg for Lasri Tech Intravenous Injection |
| 2010-700024 (■) | 2950775 | Name of sale: Laslitec Intravenous injection 7.5mg Active ingredient: Lasbricase (genetically modified) |
| 2010-700023 (○) | 2950775 | 1.5 mg for Lasri Tech Intravenous Injection |
| 2010-700023 (■) | 2950775 | Name of Sale: Laslitech Intravenous Injection 1.5 mg Active Ingredient: Las Bricase (genetically modified) |
| 2010-700022 (○) | 2948125 | 7.5mg for Lasri Tech Intravenous Injection |
| 2010-700022 (■) | 2948125 | Name of sale: Laslitec Intravenous injection 7.5mg Active ingredient: Lasbricase (genetically modified) |
| 2010-700021 (○) | 2948125 | 1.5 mg for Lasri Tech Intravenous Injection |
| 2010-700021 (■) | 2948125 | Name of Sale: Laslitech Intravenous Injection 1.5 mg Active Ingredient: Las Bricase (genetically modified) |
| 2010-700020 (○) | 2723358 | 7.5mg for Lasri Tech Intravenous Injection |
| 2010-700020 (■) | 2723358 | Name of sale: Laslitec Intravenous injection 7.5mg Active ingredient: Lasbricase (genetically modified) |
| 2010-700019 (○) | 2723358 | 1.5 mg for Lasri Tech Intravenous Injection |
| 2010-700019 (■) | 2723358 | Name of Sale: Laslitech Intravenous Injection 1.5 mg Active Ingredient: Las Bricase (genetically modified) |
| 2010-700018 (○) | 2664804 | 7.5mg for Lasri Tech Intravenous Injection |
| 2010-700018 (■) | 2664804 | Name of sale: Laslitec Intravenous injection 7.5mg Active ingredient: Lasbricase (genetically modified) |
| 2010-700017 (○) | 2664804 | 1.5 mg for Lasri Tech Intravenous Injection |
| 2010-700017 (■) | 2664804 | Name of Sale: Laslitech Intravenous Injection 1.5 mg Active Ingredient: Las Bricase (genetically modified) |
| 2010-700016 (○) | 4271586 | Common name: Aprepitant |
| 2010-700016 (■) | 4271586 | Common name: Aprepitant |
| 2010-700015 (○) | 4271586 | Common name: Aprepitant |
| 2010-700015 (■) | 4271586 | Common name: Aprepitant |
| 2010-700014 (○) | 4271586 | Common name: Aprepitant |
| 2010-700014 (■) | 4271586 | Common name: Aprepitant |
| 2010-700013 (○) | 3245424 | Common name: Aprepitant |
| 2010-700013 (■) | 3245424 | Aprepitant (Imend Capsule 125 mg) |
| 2010-700012 (○) | 3245424 | Common name: Aprepitant |
| 2010-700012 (■) | 3245424 | Aprepitant (Imend Capsule 80 mg) |
| 2010-700011 (○) | 3245424 | Common name: Aprepitant |
| 2010-700011 (■) | 3245424 | Aprepi Tant (Imend Capsule Set) |
| 2010-700010 (○) | 2634372 | Common name: Aprepitant |
| 2010-700010 (■) | 2634372 | Aprepitant (Imend Capsule 125 mg) |
| 2010-700009 (○) | 2634372 | Common name: Aprepitant |
| 2010-700009 (■) | 2634372 | Aprepitant (Imend Capsule 80 mg) |
| 2010-700008 (○) | 2634372 | Common name: Aprepitant |
| 2010-700008 (■) | 2634372 | Aprepi Tant (Imend Capsule Set) |
| 2010-700007 (○) | 3732508 | Name of sale: Symbicort Turbulehler 60 Inhalation General name: budesonide / formoterol fumarate hydrate inhalant |
| 2010-700006 (○) | 3732508 | Name of sale: Symbicort Turbulehler 30 inhalation General name: budesonide / formoterol fumarate hydrate inhalant |
| 2010-700005 (○) | 3342484 | Name of sale: Symbicort Turbulehler 60 Inhalation General name: budesonide / formoterol fumarate hydrate inhalant |
| 2010-700005 (■) | 3342484 | Name of sale: Symbicort Turbulehler 60 inhalation General name: budesonide / formoterol fumarate hydrate |
| 2010-700004 (○) | 3342484 | Name of sale: Symbicort Turbulehler 30 inhalation General name: budesonide / formoterol fumarate hydrate inhalant |
| 2010-700004 (■) | 3342484 | Name of sale: Symbicort Turb Hailer 30 Inhalation General name: Budesonide / Formoterol fumarate hydrate |
| 2010-700003 (○) | 2978247 | Name of sale: Symbicort Turbulehler 60 Inhalation General name: budesonide / formoterol fumarate hydrate inhalant |
| 2010-700002 (○) | 2978247 | Name of sale: Symbicort Turbulehler 30 inhalation General name: budesonide / formoterol fumarate hydrate inhalant |
| 2010-700001 (○) | 3487614 | Thiamethoxam-Pyroxil granules (general name) |
| 2010-100167 (○) | 4444908 | Takepron OD Tablet 15 (Lansoprazole) |
| 2010-100148 (○) | 4088036 | 3,4-Dichloro-2'-cyano-1,2-thiazole-5-carboxanilide |
| 2010-100146 (○) | 3993768 | Name of sale: Allelock OD Tablet 2.5 AlleLock OD Tablet 2.5 is a tablet manufactured using a lubricant spray type tableting machine, containing 2.5 mg of olopatadine hydrochloride in one tablet. is there. |
| 2010-100143 (○) | 3983476 | Name of sale: Allelock OD Tablet 5 AlleLock OD Tablet 5 is a tablet manufactured using a lubricant spray type tableting machine, containing 5 mg of olopatadine hydrochloride in one tablet. |
| 2010-100143 (■) | 3983476 | Active ingredient: Olopatadine hydrochloride Sales name: Alleloc OD Tablet 5 Alerok OD Tablet 5 is an orally disintegrating tablet containing 5 mg of Olopatadine hydrochloride in one tablet, and is a lubricant spray type tableting tablet. It is a tablet manufactured using a machine. |
| 2010-100083 (■) | 3874419 | Active ingredient name: Olmesartan medoxomil and azelnidipine |
| 2009-700167 (○) | 2805255 | Common Name: Metaflumizone |
| 2009-700167 (■) | 2805255 | Common Name: Metaflumizone |
| 2009-700166 (○) | 3986085 | General name: ethiprole Chemical name: 5-amino-1- (2,6-dichloro-α, α, α-trifluoro-p-tolyl) -4-ethylsulfinylpyrazole-3-carbonitrile |
| 2009-700166 (■) | 3986085 | General name: ethiprole Chemical name: 5-amino-1- (2,6-dichloro-α, α, α-trifluoro-p-tolyl) -4-ethylsulfinylpyrazole-3-carbonitrile |
| 2009-700165 (○) | 3729825 | Active ingredient (chemical name): 3-bromo-N- [4-chloro-2-methyl-6- (methylcarbamoyl) phenyl] -1- (3-chloropyridin-2-yl) -1H-pyrazole-5- Carboxamide |
| 2009-700165 (■) | 3729825 | Active ingredient (chemical name): 3-bromo-N- [4-chloro-2-methyl-6- methylcarbamoyl) phenyl] -1- (3-chloropyridin-2-yl) -1H-pyrazole- 5-carboxamide |
| 2009-700164 (○) | 3729825 | Active ingredient (chemical name): 3-bromo-N- [4-chloro-2-methyl-6- (methylcarbamoyl) phenyl] -1- (3-chloropyridin-2-yl) -1H-pyrazole -5- carboxamide |
| 2009-700164 (■) | 3729825 | Active ingredient (chemical name): 3-bromo-N- [4-chloro-2-methyl-6- methylcarbamoyl) phenyl] -1- (3-chloropyridin-2-yl) -1H-pyrazole- 5-carboxamide |
| 2009-700163 (○) | 3238409 | Morus tape L 40 mg (active ingredient: ketoprofen) |
| 2009-700163 (■) | 3238409 | Morus tape L 40 mg (active ingredient: ketoprofen) |
| 2009-700162 (○) | 3238409 | Morus tape 20 mg (active ingredient: ketoprofen) |
| 2009-700162 (■) | 3238409 | Morus tape 20 mg (active ingredient: ketoprofen) |
| 2009-700161 (○) | 2816765 | Morus tape L 40 mg (active ingredient: ketoprofen) |
| 2009-700161 (■) | 2816765 | Morus tape L 40 mg (active ingredient: ketoprofen) |
| 2009-700160 (○) | 2816765 | Morus tape 20 mg (active ingredient: ketoprofen) |
| 2009-700160 (■) | 2816765 | Morus tape 20 mg (active ingredient: ketoprofen) |
| 2009-700159 (○) | 3957765 | Bevacizumab (genetically modified) |
| 2009-700159 (■) | 3957765 | Name of sale: Avastin for intravenous drip infusion 400 mg / 16 mL Common name: bevacizumab (genetically modified) |
| 2009-700158 (○) | 3957765 | Bevacizumab (genetically modified) |
| 2009-700158 (■) | 3957765 | Name of sale: Avastin for intravenous drip infusion 100 mg / 4 mL Common name: bevacizumab (genetically modified) |
| 2009-700157 (○) | 3398382 | Bevacizumab (genetically modified) |
| 2009-700157 (■) | 3398382 | Name of sale: Avastin for intravenous drip infusion 400 mg / 16 mL Common name: bevacizumab (genetically modified) |
| 2009-700156 (○) | 3398382 | Bevacizumab (genetically modified) |
| 2009-700156 (■) | 3398382 | Name of sale: Avastin for intravenous drip infusion 100 mg / 4 mL Common name: bevacizumab (genetically modified) |
| 2009-700155 (○) | 3762407 | Common Name: Sitagliptin Phosphate Hydrate |
| 2009-700155 (■) | 3762407 | Common Name: Sitagliptin Phosphate Hydrate |
| 2009-700154 (○) | 3762407 | Common Name: Sitagliptin Phosphate Hydrate |
| 2009-700154 (■) | 3762407 | Common Name: Sitagliptin Phosphate Hydrate |
| 2009-700153 (○) | 3762407 | Common Name: Sitagliptin Phosphate Hydrate |
| 2009-700152 (○) | 3808095 | Tadarafil |
| 2009-700152 (■) | 3808095 | Tadarafil |
| 2009-700151 (○) | 3547755 | ELPLAT Intravenous Solution 100 mg |
| 2009-700150 (○) | 3547755 | ELPLAT Intravenous Solution 50 mg |
| 2009-700149 (○) | 2501297 | Capecitabine |
| 2009-700149 (■) | 2501297 | Capecitabine |
| 2009-700148 (○) | 3502574 | Vancomycin eye ointment 1% |
| 2009-700148 (■) | 3502574 | Vancomycin hydrochloride |
| 2009-700147 (○) | 2736470 | Metaiodobenzylguanidine (123 I) |
| 2009-700146 (○) | 3657002 | Darunavir ethanol adduct |
| 2009-700145 (○) | 3547755 | Oxaliplatin (Product Name: ELPLAT Intravenous Drip Solution 100mg) |
| 2009-700145 (■) | 3547755 | Oxaliplatin (Product Name: ELPLAT Intravenous Drip Solution 100mg) |
| 2009-700144 (○) | 3547755 | ELPLAT Intravenous Solution 100 mg |
| 2009-700144 (■) | 3547755 | Name of Sale: ELPLAT Intravenous Drip Solution 100mg Active Ingredient: Oxaliplatin |
| 2009-700143 (○) | 3547755 | ELPLAT Intravenous Solution 50 mg |
| 2009-700143 (■) | 3547755 | Name of sale: ELPLAT Intravenous Drip Solution 50mg Active Ingredient: Oxaliplatin |
| 2009-700142 (○) | 3547755 | Oxaliplatin (Product Name: ELPLAT Intravenous Solution 50 mg) |
| 2009-700142 (■) | 3547755 | Oxaliplatin (Product Name: ELPLAT Intravenous Solution 50 mg) |
| 2009-700141 (○) | 3691487 | Dexamethasone cipesylic ester |
| 2009-700141 (■) | 3691487 | Dexamethasone cipesylic ester |
| 2009-700140 (○) | 3113078 | 3-mesityl-2-oxo-1-oxaspiro [4.4] non-3-en-4-yl = 3,3-dimethyl butyrate |
| 2009-700140 (■) | 3113078 | 3-mesityl-2-oxo-1-oxaspiro [4.4] non-3-en-4-yl = 3,3-dimethyl butyrate |
| 2009-700139 (○) | 3113078 | 3- (2,4-Dichlorophenyl) -2-oxo-1-oxaspiro [4.5] dec-3-en-4-yl = 2,2-dimethyl butyrate |
| 2009-700139 (■) | 3113078 | 3- (2,4-Dichlorophenyl) -2-oxo-1-oxaspiro [4.5] dec-3-en-4-yl = 2,2-dimethyl butyrate |
| 2009-700138 (○) | 4234666 | Aricept Oral Jelly 10 mg General Name: Donepezil Hydrochloride |
| 2009-700138 (■) | 4234666 | Aricept Oral Jelly 10 mg General Name: Donepezil Hydrochloride |
| 2009-700137 (○) | 4234666 | Aricept internal medicine jelly 5mg General name: donepezil hydrochloride |
| 2009-700137 (■) | 4234666 | Aricept internal medicine jelly 5mg General name: donepezil hydrochloride |
| 2009-700136 (○) | 4234666 | Aricept Oral Jelly 3 mg General Name: Donepezil Hydrochloride |
| 2009-700136 (■) | 4234666 | Aricept Oral Jelly 3 mg General Name: Donepezil Hydrochloride |
| 2009-700135 (○) | 3506336 | Amlodipine besylate / atorvastatin calcium hydrate |
| 2009-700135 (■) | 3506336 | Amlodipine besylate / atorvastatin calcium hydrate |
| 2009-700134 (○) | 3506336 | Amlodipine besylate / atorvastatin calcium hydrate |
| 2009-700134 (■) | 3506336 | Amlodipine besylate / atorvastatin calcium hydrate |
| 2009-700133 (○) | 3506336 | Amlodipine besylate / atorvastatin calcium hydrate |
| 2009-700133 (■) | 3506336 | Amlodipine besylate / atorvastatin calcium hydrate |
| 2009-700132 (○) | 3506336 | Amlodipine besylate / atorvastatin calcium hydrate |
| 2009-700132 (■) | 3506336 | Amlodipine besylate / atorvastatin calcium hydrate |
| 2009-700131 (○) | 3296564 | Amlodipine besylate / atorvastatin calcium hydrate |
| 2009-700130 (○) | 3296564 | Amlodipine besylate / atorvastatin calcium hydrate |
| 2009-700129 (○) | 3296564 | Amlodipine besylate / atorvastatin calcium hydrate |
| 2009-700128 (○) | 3296564 | Amlodipine besylate / atorvastatin calcium hydrate |
| 2009-700127 (○) | 3240322 | Name of sale: RADIOS Tablet 150 mg Common name: Aliskiren fumarate |
| 2009-700127 (■) | 3240322 | Name of sale: RADIOS Tablet 150 mg Common name: Aliskiren fumarate |
| 2009-700126 (○) | 2904310 | Dutasteride |
| 2009-700126 (■) | 2904310 | Dutasteride |
| 2009-700125 (○) | 3487614 | Thiamethoxam granules (general name) |
| 2009-700124 (○) | 3487614 | Thiamethoxam granules (general name) |
| 2009-700123 (○) | 3487614 | Thiamethoxam granules (general name) |
| 2009-700122 (○) | 3487614 | Thiamethoxam granules (general name) |
| 2009-700121 (○) | 3487614 | Thiamethoxam granules (general name) |
| 2009-700121 (■) | 3487614 | Thiamethoxam granules (general name) |
| 2009-700120 (○) | 3487614 | Thiamethoxam water solvent (common name) |
| 2009-700119 (○) | 3487614 | Thiamethoxam water solvent (common name) |
| 2009-700118 (○) | 3487614 | Thiamethoxam water solvent (common name) |
| 2009-700117 (○) | 3487614 | Thiamethoxam water solvent (common name) |
| 2009-700116 (○) | 3487614 | Thiamethoxam water solvent (common name) |
| 2009-700115 (○) | 3946445 | Common name: mometasone furan carboxylic acid ester |
| 2009-700115 (■) | 3946445 | Name of sale: Asmonex Twist Heller 200 μg 60 Inhaled Common name of active ingredient: Mometasone furan carboxylic acid ester |
| 2009-700114 (○) | 3946445 | Common name: mometasone furan carboxylic acid ester |
| 2009-700114 (■) | 3946445 | Name of sale: Asmonex Twist Heller 100 μg 60 inhalation Common name of active ingredient: Mometasone furan carboxylic acid ester |
| 2009-700113 (○) | 3901738 | Common name: mometasone furan carboxylic acid ester |
| 2009-700113 (■) | 3901738 | Name of sale: Asmonex Twist Heller 200 μg 60 Inhaled Common name of active ingredient: Mometasone furan carboxylic acid ester |
| 2009-700112 (○) | 3901738 | Common name: mometasone furan carboxylic acid ester |
| 2009-700112 (■) | 3901738 | Name of sale: Asmonex Twist Heller 100 μg 60 inhalation Common name of active ingredient: Mometasone furan carboxylic acid ester |
| 2009-700111 (○) | 2994182 | Flonicamid |
| 2009-700111 (■) | 2994182 | Flonicamid |
| 2009-700110 (○) | 3622983 | I) General name: oseltamivir phosphate ii) Name: Tamiflu dry syrup 3% |
| 2009-700109 (○) | 3300365 | I) General name: oseltamivir phosphate ii) Name: Tamiflu dry syrup 3% |
| 2009-700108 (○) | 3487614 | Thiamethoxam azoxystrobin wettable powder (general name) |
| 2009-700107 (○) | 3487614 | Thiamethoxam wettable powder (general name) |
| 2009-700106 (○) | 3502342 | I) General name: oseltamivir phosphate ii) Name: Tamiflu dry syrup 3% |
| 2009-700105 (○) | 3681068 | Bimatoprost |
| 2009-700105 (■) | 3681068 | Bimatoprost |
| 2009-700104 (○) | 3734796 | 1- {3-[(4,6-dimethoxypyrimidin-2-ylcarbamoyl) sulfamoyl] -2-pyridyl} -2-fluoropropyl = methoxyacetate |
| 2009-700104 (■) | 3734796 | 1- {3-[(4,6-dimethoxypyrimidin-2-ylcarbamoyl) sulfamoyl] -2-pyridyl} -2-fluoropropyl = methoxyacetate |
| 2009-700103 (○) | 3734796 | 1- (4,6-Dimethoxypyrimidin-2-yl) -3- [1-methyl-4- (2-methyl-2H-tetrazol-5-yl) pyrazol-5-ylsulfonyl] urea (RS) -ethyl 2-chloro-3- [2-chloro-5- (4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazole-1 -Yl) -4-fluorophenyl] propionate 1- {3-[(4,6-dimethoxypyrimidin-2-ylcarbamoyl) sulfamoyl] -2-pyridyl} -2-fluoropropyl = methoxyacetate |
| 2009-700103 (■) | 3734796 | 1- (4,6-Dimethoxypyrimidin-2-yl) -3- [1-methyl-4- (2-methyl-2H-tetrazol-5-yl) pyrazol-5-ylsulfonyl] urea (RS) -ethyl 2-chloro-3- [2-chloro-5- (4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazole-1 -Yl) -4-fluorophenyl] propionate 1- {3-[(4,6-dimethoxypyrimidin-2-ylcarbamoyl) sulfamoyl] -2-pyridyl} -2-fluoropropyl = methoxyacetate |
| 2009-700102 (○) | 3734796 | 2-methylthio-4,6-bis (ethylamino) -s-triazine 1- {3-[(4,6-dimethoxypyrimidin-2-ylcarbamoyl) sulfamoyl] -2-pyridyl} -2 -Fluoropropyl = methoxyacetate 2,3-dihydro-3,3-dimethylbenzofuran-5-yl ethanesulfonate |
| 2009-700102 (■) | 3734796 | 2-methylthio-4,6-bis (ethylamino) -s-triazine 1- {3-[(4,6-dimethoxypyrimidin-2-ylcarbamoyl) sulfamoyl] -2-pyridyl} -2 -Fluoropropyl = methoxyacetate 2,3-dihydro-3,3-dimethylbenzofuran-5-yl ethanesulfonate |
| 2009-700101 (○) | 3734796 | 1- {3-[(4,6-dimethoxypyrimidin-2-ylcarbamoyl) sulfamoyl] -2-pyridyl} -2-fluoropropyl = methoxyacetate |
| 2009-700101 (■) | 3734796 | 1- {3-[(4,6-dimethoxypyrimidin-2-ylcarbamoyl) sulfamoyl] -2-pyridyl} -2-fluoropropyl = methoxyacetate |
| 2009-700100 (○) | 3986085 | General name: ethiprole Chemical name: 5-amino-1- (2,6-dichloro-α, α, α-trifluoro-p-tolyl) -4-ethylsulfinylpyrazole-3-carbonitrile |
| 2009-700100 (■) | 3986085 | General name: ethiprole Chemical name: 5-amino-1- (2,6-dichloro-α, α, α-trifluoro-p-tolyl) -4-ethylsulfinylpyrazole-3-carbonitrile |
| 2009-700099 (○) | 3000240 | Methyl = (E) -methoxyimino-{(E) -α- [1- (α, α, α-trifluoro-m-tolyl) ethylideneaminooxy] -o-tolyl acetate |
| 2009-700099 (■) | 3000240 | Methyl = (E) -methoxyimino-{(E) -α- [1- (α, α, α-trifluoro-m-tolyl) ethylideneaminooxy] -o-tolyl acetate |
| 2009-700098 (○) | 3016876 | Pemetrexed sodium hydrate |
| 2009-700098 (■) | 3016876 | Pemetrexed sodium hydrate |
| 2009-700097 (○) | 3016876 | Pemetrexed sodium hydrate |
| 2009-700097 (■) | 3016876 | Pemetrexed sodium hydrate |
| 2009-700096 (○) | 3845792 | Solaf Enib tosylate |
| 2009-700096 (■) | 3845792 | Solaf Enib tosylate |
| 2009-700095 (○) | 3068033 | (A) Drugs subject to disposal (brand name) Epogin injection ampoule 12000 b) Active ingredients of drug subject to disposal (general name) epoetin beta (genetically modified) |
| 2009-700094 (○) | 3068033 | (A) Drugs subject to disposal (brand name) Epogin injection ampoule 9000 Active ingredients of drug subject to disposal (general name) Epoetin beta (genetically modified) |
| 2009-700093 (○) | 3068033 | (A) Drugs subject to disposal (brand name) Epogin injection ampoule 6000 Active ingredients of drug subject to disposal (general name) Epoetin beta (genetically modified) |
| 2009-700092 (○) | 3068033 | (A) Drugs subject to disposal (brand name) Epogin injection ampoule 3000 Active ingredients of drugs subject to disposal (general name) Epoetin beta (genetically modified) |
| 2009-700091 (○) | 3068033 | (A) Drugs subject to disposal (brand name) Epogin injection ampoule 1500 Active ingredients of drug subject to disposal (general name) Epoetin beta (genetically modified) |
| 2009-700090 (○) | 3068033 | (A) Drugs subject to disposal (brand name) Epogin injection ampoule 750 a) Active ingredients of drugs subject to disposal (general name) Epoetin beta (genetically modified) |
| 2009-700089 (○) | 3068033 | (A) Drugs subject to disposal (brand name) Epogin injection syringe 12000 b) Active ingredients of drugs subject to disposal (general name) Epoetin beta (genetically modified) |
| 2009-700088 (○) | 3068033 | (A) Drugs subject to disposal (brand name) Epogin injection syringe 9000 Active ingredients of drugs subject to disposal (general name) Epoetin beta (genetically modified) |
| 2009-700087 (○) | 3068033 | (A) Drugs subject to disposal (brand name) Epogin injection syringe 6000 Active ingredients of drug subject to disposal (general name) Epoetin beta (genetically modified) |
| 2009-700086 (○) | 3068033 | (A) Drugs subject to disposal (brand name) Epogin injection syringe 3000 Active ingredients of drugs subject to disposal (general name) Epoetin beta (genetically modified) |
| 2009-700085 (○) | 3068033 | (A) Drugs subject to disposal (brand name) Epogin injection syringe 1500 Active ingredients of drug subject to disposal (general name) Epoetin beta (genetically modified) |
| 2009-700084 (○) | 3068033 | (A) Drugs subject to disposal (brand name) Epogin injection syringe 750 Active ingredients of drugs subject to disposal (general name) Epoetin beta (genetically modified) |
| 2009-700083 (○) | 3645906 | Drugs subject to disposal (brand name) Risperdal consta 50 mg for intramuscular injection active ingredients of drug subject to disposal (general name) risperidone |
| 2009-700083 (■) | 3645906 | Drugs subject to disposal (brand name) Risperdal consta 50 mg for intramuscular injection active ingredients of drug subject to disposal (general name) risperidone |
| 2009-700082 (○) | 3645906 | Drugs subject to disposal (brand name) Risperdal 37.5mg for intramuscular injection active ingredients of drug subject to disposal (general name) risperidone |
| 2009-700082 (■) | 3645906 | Drugs subject to disposal (brand name) Risperdal 37.5mg for intramuscular injection active ingredients of drug subject to disposal (general name) risperidone |
| 2009-700081 (○) | 3645906 | Drugs subject to disposal (brand name) Risperdal consta 25 mg for intramuscular injection active ingredients of drug subject to disposal (general name) risperidone |
| 2009-700081 (■) | 3645906 | Drugs subject to disposal (brand name) Risperdal consta 25 mg for intramuscular injection active ingredients of drug subject to disposal (general name) risperidone |
| 2009-700080 (○) | 4231292 | Active ingredient (common name): insulin glulysin (genetically modified) |
| 2009-700080 (■) | 4231292 | Active ingredient (common name): insulin glulysin (genetically modified) |
| 2009-700079 (○) | 4231292 | Active ingredient (common name): insulin glulysin (genetically modified) |
| 2009-700079 (■) | 4231292 | Active ingredient (common name): insulin glulysin (genetically modified) |
| 2009-700078 (○) | 4231292 | Active ingredient (common name): insulin glulysin (genetically modified) |
| 2009-700078 (■) | 4231292 | Active ingredient (common name): insulin glulysin (genetically modified) |
| 2009-700077 (○) | 4231292 | Active ingredient (common name): insulin glulysin (genetically modified) |
| 2009-700077 (■) | 4231292 | Active ingredient (common name): insulin glulysin (genetically modified) |
| 2009-700076 (○) | 3676573 | Active ingredient (common name): insulin glulysin (genetically modified) |
| 2009-700076 (■) | 3676573 | Active ingredient (common name): insulin glulysin (genetically modified) |
| 2009-700075 (○) | 3676573 | Active ingredient (common name): insulin glulysin (genetically modified) |
| 2009-700075 (■) | 3676573 | Active ingredient (common name): insulin glulysin (genetically modified) |
| 2009-700074 (○) | 3676573 | Active ingredient (common name): insulin glulysin (genetically modified) |
| 2009-700074 (■) | 3676573 | Active ingredient (common name): insulin glulysin (genetically modified) |
| 2009-700073 (○) | 3676573 | Active ingredient (common name): insulin glulysin (genetically modified) |
| 2009-700073 (■) | 3676573 | Active ingredient (common name): insulin glulysin (genetically modified) |
| 2009-700072 (○) | 2889549 | Doxorubicin hydrochloride |
| 2009-700072 (■) | 2889549 | Doxorubicin hydrochloride |
| 2009-700071 (○) | 2667051 | Doxorubicin hydrochloride |
| 2009-700071 (■) | 2667051 | Doxorubicin hydrochloride |
| 2009-700070 (○) | 4181215 | Valganciclovir Hydrochloride (VALIXA Tablets 450 mg) |
| 2009-700070 (■) | 4181215 | Valganciclovir Hydrochloride (VALIXA Tablets 450 mg) |
| 2009-700069 (○) | 4094667 | Valganciclovir Hydrochloride (VALIXA Tablets 450 mg) |
| 2009-700069 (■) | 4094667 | Valganciclovir Hydrochloride (VALIXA Tablets 450 mg) |
| 2009-700068 (○) | 4094666 | Valganciclovir Hydrochloride (VALIXA Tablets 450 mg) |
| 2009-700068 (■) | 4094666 | Valganciclovir Hydrochloride (VALIXA Tablets 450 mg) |
| 2009-700067 (○) | 4091115 | Valganciclovir Hydrochloride (VALIXA Tablets 450 mg) |
| 2009-700067 (■) | 4091115 | Valganciclovir Hydrochloride (VALIXA Tablets 450 mg) |
| 2009-700066 (○) | 3090305 | Valganciclovir Hydrochloride (VALIXA Tablets 450 mg) |
| 2009-700066 (■) | 3090305 | Valganciclovir Hydrochloride (VALIXA Tablets 450 mg) |
| 2009-700065 (○) | 3563036 | Celecoxib (brand name: Celecox Tablet 100 mg) |
| 2009-700065 (■) | 3563036 | Celecoxib (brand name: Celecox Tablet 100 mg) |
| 2009-700064 (○) | 3563036 | Celecoxib (brand name: Celecox Tablet 200 mg) |
| 2009-700064 (■) | 3563036 | Celecoxib (brand name: Celecox Tablet 200 mg) |
| 2009-700063 (○) | 3025017 | Celecoxib (brand name: Celecox Tablet 100 mg) |
| 2009-700063 (■) | 3025017 | Celecoxib (brand name: Celecox Tablet 100 mg) |
| 2009-700062 (○) | 3025017 | Celecoxib (brand name: Celecox Tablet 200 mg) |
| 2009-700062 (■) | 3025017 | Celecoxib (brand name: Celecox Tablet 200 mg) |
| 2009-700061 (○) | 3317649 | Tevipenem Pivoxil |
| 2009-700061 (■) | 3317649 | Tevipenem Pivoxil |
| 2009-700060 (○) | 3317603 | Tevipenem Pivoxil |
| 2009-700060 (■) | 3317603 | Tevipenem Pivoxil |
| 2009-700059 (○) | 4102185 | Lapatinib tosylate hydrate |
| 2009-700059 (■) | 4102185 | Lapatinib tosylate hydrate |
| 2009-700058 (○) | 3390741 | Lapatinib tosylate hydrate |
| 2009-700058 (■) | 3390741 | Lapatinib tosylate hydrate |
| 2009-700057 (○) | 3256841 | Pioglitazone hydrochloride (brand name: Actos Tablet 30) |
| 2009-700057 (■) | 3256841 | Pioglitazone hydrochloride (brand name: Actos Tablet 30) |
| 2009-700056 (○) | 3256841 | Pioglitazone hydrochloride (brand name: Actos Tablet 15) |
| 2009-700056 (■) | 3256841 | Pioglitazone hydrochloride (brand name: Actos Tablet 15) |
| 2009-700055 (○) | 2788084 | Valganciclovir Hydrochloride (VALIXA Tablets 450 mg) |
| 2009-700055 (■) | 2788084 | Valganciclovir hydrochloride |
| 2009-700054 (○) | 3535872 | Botulinum toxin type A |
| 2009-700054 (■) | 3535872 | Name of sale: Botox injection 100 Active ingredient: Botulinum toxin type A |
| 2009-700053 (○) | 4072195 | Mitiglinide calcium hydrate |
| 2009-700053 (■) | 4072195 | Mitiglinide calcium hydrate |
| 2009-700052 (○) | 4072195 | Mitiglinide calcium hydrate |
| 2009-700052 (■) | 4072195 | Mitiglinide calcium hydrate |
| 2009-700051 (○) | 2686863 | Mitiglinide calcium hydrate |
| 2009-700051 (■) | 2686863 | Mitiglinide calcium hydrate |
| 2009-700050 (○) | 2686863 | Mitiglinide calcium hydrate |
| 2009-700050 (■) | 2686863 | Mitiglinide calcium hydrate |
| 2009-700049 (○) | 3487614 | Emamectin benzoate, thiamethoxam, difenoconazole water solvent (general name) |
| 2009-700048 (○) | 3487614 | Emamectin benzoate, thiamethoxam, difenoconazole water solvent (general name) |
| 2009-700048 (■) | 3487614 | Name of Pesticide: Gardi SG Active Ingredient: (i) Emamectin Benzoate ii) 3- (2-Chloro-1,3-thiazol-5-ylmethyl) -5-methyl-1,3, 5-oxadiazinan-4-ylidene (nitro) amine iii) cis-trans-3-chloro-4- [4-methyl-2- (1H-1,2,4-triazol-1-ylmethyl) -1 , 3-Dioxolan-2-yl] phenyl 4-chlorophenyl = ether |
| 2009-700047 (○) | 3487614 | Emamectin benzoate, thiamethoxam, difenoconazole solution (general name) |
| 2009-700047 (■) | 3487614 | Name of Pesticide: Gardi AL Active Ingredient: i) Emamectin Benzoate ii) 3- (2-Chloro-1,3-thiazol-5-ylmethyl) -5-methyl-1, 3,5-Oxadiazinan-4-ylidene (nitro) amine iii) cis-trans-3-chloro-4- [4-methyl-2- (1H-1,2,4-triazol-1-ylmethyl) 1,3-Dioxolan-2-yl] phenyl = 4-chlorophenyl ether |
| 2009-700043 (○) | 3957765 | Ranibizumab (genetically modified) |
| 2009-700043 (■) | 3957765 | Ranibizumab (genetically modified) |
| 2009-700042 (○) | 345792 | (Sale name) Zorea for subcutaneous injection |
| 2009-700042 (■) | 345792 | Name (sold name): Zolea for subcutaneous injection Active ingredient: omalizumab (genetically modified) |
| 2009-700041 (■) | 3743449 | Name of sale: Remitch capsule 2.5 μg Active ingredient: Nalfurafine hydrochloride (general name) |
| 2009-700040 (○) | 2525552 | Name of sale: Remitch capsule 2.5 μg Active ingredient: Nalfurafine hydrochloride (general name) |
| 2009-700040 (■) | 2525552 | Name of sale: Remitch capsule 2.5 μg Active ingredient: Nalfurafine hydrochloride (general name) |
| 2009-700039 (○) | 3057471 | Candesartan cilexetil, hydrochlorothiazide |
| 2009-700039 (■) | 3057471 | Candesartan cilexetil, hydrochlorothiazide |
| 2009-700038 (○) | 3057471 | Candesartan cilexetil, hydrochlorothiazide |
| 2009-700038 (■) | 3057471 | Candesartan cilexetil, hydrochlorothiazide |
| 2009-700037 (○) | 2514282 | Ecard combination tablet LD (combination drug of candesartan cilexetil and hydrochlorothiazide) |
| 2009-700037 (■) | 2514282 | Ecard combination tablet HD (combination drug of candesartan cilexetil and hydrochlorothiazide) |
| 2009-700036 (○) | 2514282 | Ecard combination tablet LD (combination drug of candesartan cilexetil and hydrochlorothiazide) |
| 2009-700036 (■) | 2514282 | Ecard combination tablet LD (combination drug of candesartan cilexetil and hydrochlorothiazide) |
| 2009-700035 (○) | 2749458 | Valsartan and hydrochlorothiazide |
| 2009-700035 (■) | 2749458 | Valsartan and hydrochlorothiazide |
| 2009-700034 (○) | 2749458 | Valsartan and hydrochlorothiazide |
| 2009-700034 (■) | 2749458 | Valsartan and hydrochlorothiazide |
| 2009-700033 (○) | 4110140 | Nilotinib hydrochloride hydrate |
| 2009-700033 (■) | 4110140 | Nilotinib hydrochloride hydrate |
| 2009-700032 (○) | 3042867 | Salmeterol xinafoate and fluticasone propionate |
| 2009-700032 (■) | 3042867 | Salmeterol xinafoate and fluticasone propionate |
| 2009-700031 (■) | 3026840 | Name of sale: Ad air 50 air 120 for inhalation Changed name for sale: Ad air 50 aerosol 120 for inhalation) General name: salmeterol xinafoate, fluticasone propionate |
| 2009-700030 (■) | 3989175 | Salmeterol xinafoate, fluticasone propionate and fluorocarbon 134a |
| 2009-700029 (○) | 3989175 | Common Name: Dasatinib Hydrate (Name: Sprisel Tablets 20 mg |
| 2009-700029 (■) | 3989175 | Common Name: Dasatinib Hydrate Sales Name: Sprycel Tablet 50 mg |
| 2009-700028 (○) | 3364481 | Zonisamide |
| 2009-700028 (■) | 3364481 | Zonisamide |
| 2009-700027 (○) | 3385208 | Minodronic acid hydrate |
| 2009-700027 (■) | 3385208 | Minodronic acid hydrate |
| 2009-700026 (○) | 3635238 | Etravirin |
| 2009-700026 (■) | 3635238 | Etravirin |
| 2009-700025 (○) | 4171091 | Nateglinide |
| 2009-700025 (■) | 4171091 | Nateglinide |
| 2009-700024 (○) | 4171091 | Nateglinide |
| 2009-700024 (■) | 4171091 | Nateglinide |
| 2009-700023 (○) | 2508949 | Nateglinide |
| 2009-700023 (■) | 2508949 | Nateglinide |
| 2009-700022 (○) | 3973280 | Pioglitazone hydrochloride (brand name; Actos Tablet 30) |
| 2009-700022 (■) | 3973280 | Pioglitazone hydrochloride (brand name: Actos Tablet 30) |
| 2009-700021 (○) | 3973280 | Pioglitazone hydrochloride (brand name: Actos Tablet 15) |
| 2009-700021 (■) | 3973280 | Pioglitazone hydrochloride (brand name: Actos Tablet 15) |
| 2009-700020 (○) | 3256841 | Pioglitazone hydrochloride (brand name: Actos Tablet 30) |
| 2009-700020 (■) | 3256841 | Pioglitazone hydrochloride (brand name: Actos Tablet 30) |
| 2009-700019 (○) | 3256841 | Pioglitazone hydrochloride (brand name: Actos Tablet 15) |
| 2009-700019 (■) | 3256841 | Pioglitazone hydrochloride (brand name: Actos Tablet 15) |
| 2009-700018 (○) | 3693957 | Malabirok |
| 2009-700018 (■) | 3693957 | Malabirok |
| 2009-700017 (○) | 3602795 | Malabirok |
| 2009-700017 (■) | 3602795 | Malabirok |
| 2009-700016 (○) | 1941324 | Azoxystrobin wettable powder (general name: Amister 20 flowable) |
| 2009-700016 (■) | 1941324 | Azoxystrobin wettable powder (General name: Amister 20 flowable) |
| 2009-700015 (○) | 4054992 | (E) -2- (4-tert-Butylphenyl) -2-cyano-1- (1,3,4-trimethylpyrazol-5-yl) vinyl = 2, 2-dimethyl propionate |
| 2009-700015 (■) | 4054992 | (E) -2- (4-tert-Butylphenyl) -2-cyano-1- (1,3,4-trimethylpyrazol-5-yl) vinyl = 2,2-dimethyl propionate |
| 2009-700014 (○) | 3310301 | Maxacalcitol (general name) |
| 2009-700014 (■) | 3310301 | Maxacalcitol (general name) |
| 2009-700013 (○) | 4060347 | Maxacalcitol (general name) |
| 2009-700013 (■) | 4060347 | Oxalol lotion 25 μg / g (brand name) maxacalcitol (active ingredient) |
| 2009-700012 (○) | 2994182 | Flonicamid |
| 2009-700012 (■) | 2994182 | Flonicamid |
| 2009-700011 (○) | 1941324 | Azoxystrobin-TPN wettable powder (general name: Amister Optiflowable) |
| 2009-700011 (■) | 1941324 | Azoxystrobin-TPN wettable powder (General name: Amister Optiflowable) |
| 2009-700010 (○) | 1963877 | Minodronic acid hydrate |
| 2009-700010 (■) | 1963877 | Minodronic acid hydrate |
| 2009-700009 (○) | 3402604 | Human thyrotropin alpha (genetically modified) |
| 2009-700009 (■) | 3402604 | Human thyrotropin alpha (genetically modified) |
| 2009-700008 (○) | 3876355 | Tapros eye drop 0.0015% (active ingredient: tafluprost) |
| 2009-700008 (■) | 3876355 | Tafluprost |
| 2009-700007 (○) | 3480549 | Tapros eye drop 0.0015% (active ingredient: tafluprost) |
| 2009-700007 (■) | 3480549 | Tafluprost |
| 2009-700006 (○) | 3224544 | Lanthanum carbonate hydrate (brand name: Hosurenol chewable tablet 500 mg) |
| 2009-700006 (■) | 3224544 | Lanthanum carbonate hydrate (Product Name: Hosurenol Chewable Tablet 500 mg) |
| 2009-700005 (○) | 3224544 | Lanthanum carbonate hydrate (brand name: Hosurenol chewable tablet 250 mg) |
| 2009-700005 (■) | 3224544 | Lanthanum carbonate hydrate (Sale name: Hosurenol chewable tablet 250 mg) |
| 2009-700004 (○) | 4077320 | Pirfenidone |
| 2009-700004 (■) | 4077320 | Pirfenidone |
| 2009-700003 (○) | 1838915 | Pirfenidone |
| 2009-700003 (■) | 1838915 | Pirfenidone |
| 2009-700001 (○) | 3987130 | Cyazofamid |
| 2009-700001 (■) | 3987130 | Cyazofamid |
| 2009-00153 (■) | 3762407 | Common Name: Sitagliptin Phosphate Hydrate |
| 2008-700123 (○) | 2805255 | Common Name: Metaflumizone (Sale Name: Promelis Cat) |
| 2008-700123 (■) | 2805255 | Common name: Metaflumizone (market name Promelis Cat) |
| 2008-700122 (○) | 3573713 | Adehoville Pivoxil |
| 2008-700122 (■) | 3573713 | Adehoville Pivoxil |
| 2008-700121 (○) | 3164385 | Adehoville Pivoxil |
| 2008-700121 (■) | 3164385 | Adehoville Pivoxil |
| 2008-700120 (○) | 2994182 | Flonicamid |
| 2008-700120 (■) | 2994182 | Flonicamid |
| 2008-700119 (○) | 2701978 | Common name: nitric oxide |
| 2008-700119 (■) | 2701978 | Common name: nitric oxide |
| 2008-700118 (○) | 3626503 | Pegaptanib sodium (brand name: McGen intravitreal injection kit 0.3 mg) |
| 2008-700118 (■) | 3626503 | Pegaptanib sodium |
| 2008-700117 (○) | 3480736 | Common name: mometasone furan carboxylic acid ester hydrate |
| 2008-700117 (■) | 3480736 | Common name: mometasone furan carboxylic acid ester hydrate |
| 2008-700116 (○) | 3480736 | Common name: mometasone furan carboxylic acid ester hydrate |
| 2008-700116 (■) | 3480736 | Common name: mometasone furan carboxylic acid ester hydrate |
| 2008-700115 (○) | 1988571 | Common name: mometasone furan carboxylic acid ester hydrate |
| 2008-700115 (■) | 1988571 | Common name: mometasone furan carboxylic acid ester hydrate |
| 2008-700114 (○) | 1988571 | Common name: mometasone furan carboxylic acid ester hydrate |
| 2008-700114 (■) | 1988571 | Common name: mometasone furan carboxylic acid ester hydrate |
| 2008-700113 (○) | 3714970 | Grascepter capsule 5 mg |
| 2008-700113 (■) | 3714970 | Graceptor capsule 5 mg, tacrolimus |
| 2008-700112 (○) | 3714970 | Grasceptor capsule 1 mg |
| 2008-700112 (■) | 3714970 | Graceptor capsule 1 mg, tacrolimus |
| 2008-700111 (○) | 3714970 | Grascepter capsule 0.5 mg |
| 2008-700111 (■) | 3714970 | Graceptor capsule 0.5 mg, tacrolimus |
| 2008-700110 (○) | 3306473 | Tazobactam / piperacillin hydrate |
| 2008-700110 (■) | 3306473 | Tazobactam / piperacillin hydrate |
| 2008-700109 (○) | 3781308 | Argatroban hydrate |
| 2008-700109 (■) | 3781308 | Argatroban hydrate |
| 2008-700108 (○) | 3164762 | Types of Pesticide: Penthiopyra Dos Hydrant Name of Pesticide: Gaia Granulosa Hydrate |
| 2008-700108 (■) | 3164762 | Types of Pesticide: Penthiopyra Dos Hydrant Name of Pesticide: Gaia Granulosa Hydrate |
| 2008-700107 (○) | 3164762 | Types of Pesticide: Penthiopyra Dos Hydrant Name of Pesticide: AFFET FROuble 15 |
| 2008-700107 (■) | 3164762 | Types of Pesticide: Penthiopyra Dos Hydrant Name of Pesticide: AFFET FROuble 15 |
| 2008-700106 (○) | 3164762 | Types of Pesticide: Penthiopyra Dos Hydrate Name of Pesticide: Afett Frobble |
| 2008-700106 (■) | 3164762 | Types of Pesticide: Penthiopyra Dos Hydrate Name of Pesticide: Afett Frobble |
| 2008-700105 (○) | 3689104 | Ramosetron hydrochloride |
| 2008-700105 (■) | 3689104 | Ramosetron hydrochloride |
| 2008-700104 (○) | 3763360 | Ramosetron hydrochloride |
| 2008-700104 (■) | 3763360 | Ramosetron hydrochloride |
| 2008-700103 (○) | 1900712 | Ramosetron hydrochloride |
| 2008-700103 (■) | 1900712 | Ramosetron hydrochloride |
| 2008-700102 (○) | 2042892 | General Name: Metconazole Chemical Name: (1 RS, 5 RS; 1 RS, 5 SR) -5- (4-Chlorobenzyl)-2, 2-Dimethyl- 1-1 H 1, 2, 4- Triazole- 1-ylmethyl) synchropentanol |
| 2008-700102 (■) | 2042892 | General Name: Metconazole Chemical Name: (1RS, 5RS; 1RS, 5SR) -5- (4-Chlorobenzyl) -2,2-dimethyl-1- (1H-1,2,4-triazole-1 Ylmethyl) cyclopentanol |
| 2008-700101 (○) | 2585475 | Basiliximab (genetically modified) |
| 2008-700100 (○) | 3926416 | (1RS, 5RS; 1RS, 5SR) -5- (4-chlorobenzyl) -2,2-dimethyl-1- 1H-1,2,4-triazol-1-ylmethyl) cyclopentanol |
| 2008-700099 (○) | 3113078 | 3-mesityl-2-oxo-1-oxaspiro [4.4] non-3-en-4-yl = 3,3-dimethyl butyrate |
| 2008-700099 (■) | 3113078 | 3-mesityl-2-oxo-1-oxaspiro [4.4] non-3-en-4-yl = 3,3-dimethyl butyrate |
| 2008-700098 (○) | 3202234 | Fludarabine phosphate |
| 2008-700098 (■) | 3202234 | Fludarabine phosphate |
| 2008-700097 (○) | 3987130 | Cyazofamid TPN |
| 2008-700097 (■) | 3987130 | Cyazofamid TPN |
| 2008-700096 (○) | 3987130 | Cyazofamid |
| 2008-700096 (■) | 3987130 | Cyazofamid |
| 2008-700095 (○) | 2771243 | N- (2,3-Dichloro-4-hydroxyphenyl) -1-methylcyclohexanecarboxamide |
| 2008-700095 (■) | 2771243 | N- (2,3-Dichloro-4-hydroxyphenyl) -1-methylcyclohexanecarboxamide |
| 2008-700094 (○) | 3986085 | General name: ethiprole Chemical name: 5-amino-1- (2,6-dichloro-α, α, α-trifluoro-p-tolyl) -4-ethylsulfinylpyrazole-3-carbonitrile |
| 2008-700093 (○) | 3986085 | General name: ethiprole Chemical name: 5-amino-1- (2,6-dichloro-α, α, α-trifluoro-p-tolyl) -4-ethylsulfinylpyrazole-3-carbonitrile |
| 2008-700093 (■) | 3986085 | General name: ethiprole Chemical name: 5-amino-1- (2,6-dichloro-α, α, α-trifluoro-p-tolyl) -4-ethylsulfinylpyrazole-3-carbonitrile |
| 2008-700092 (○) | 3792698 | Tocilizumab (genetically modified) |
| 2008-700092 (■) | 3792698 | Tocilizumab (genetically modified) |
| 2008-700091 (○) | 3792698 | Tocilizumab (genetically modified) |
| 2008-700091 (■) | 3792698 | Tocilizumab (genetically modified) |
| 2008-700090 (○) | 3792698 | Tocilizumab (genetically modified) |
| 2008-700090 (■) | 3792698 | Tocilizumab (genetically modified) |
| 2008-700089 (○) | 3822137 | Tocilizumab (genetically modified) |
| 2008-700089 (■) | 3822137 | Tocilizumab (genetically modified) |
| 2008-700088 (○) | 3822137 | Tocilizumab (genetically modified) |
| 2008-700088 (■) | 3822137 | Tocilizumab (genetically modified) |
| 2008-700087 (○) | 3822137 | Tocilizumab (genetically modified) |
| 2008-700087 (■) | 3822137 | Tocilizumab (genetically modified) |
| 2008-700086 (○) | 3950834 | Tocilizumab (genetically modified) |
| 2008-700086 (■) | 3950834 | Tocilizumab (genetically modified) |
| 2008-700085 (○) | 3950834 | Tocilizumab (genetically modified) |
| 2008-700085 (■) | 3950834 | Tocilizumab (genetically modified) |
| 2008-700084 (○) | 3950834 | Tocilizumab (genetically modified) |
| 2008-700084 (■) | 3950834 | Tocilizumab (genetically modified) |
| 2008-700083 (○) | 3510858 | Tocilizumab (genetically modified) |
| 2008-700083 (■) | 3510858 | Tocilizumab (genetically modified) |
| 2008-700082 (○) | 3510858 | Tocilizumab (genetically modified) |
| 2008-700082 (■) | 3510858 | Tocilizumab (genetically modified) |
| 2008-700081 (○) | 3510858 | Tocilizumab (genetically modified) |
| 2008-700081 (■) | 3510858 | Tocilizumab (genetically modified) |
| 2008-700080 (○) | 2998976 | Tocilizumab (genetically modified) |
| 2008-700079 (○) | 2865300 | Tocilizumab (genetically modified) |
| 2008-700078 (○) | 2998976 | Tocilizumab (genetically modified) |
| 2008-700077 (○) | 2865300 | Tocilizumab (genetically modified) |
| 2008-700076 (○) | 2865300 | Tocilizumab (genetically modified) |
| 2008-700075 (○) | 3541042 | Deferasirox |
| 2008-700075 (■) | 3541042 | Deferasirox |
| 2008-700074 (○) | 3541042 | Deferasirox |
| 2008-700074 (■) | 3541042 | Deferasirox |
| 2008-700073 (○) | 3162626 | Avapro Tablet 100 mg |
| 2008-700073 (■) | 3162626 | Avapro Tablet 100 mg (active ingredient: irbesartan) |
| 2008-700072 (○) | 3162626 | Avapro Tablet 50 mg |
| 2008-700072 (■) | 3162626 | Avapro 50 mg (active ingredient: irbesartan) |
| 2008-700071 (○) | 3162626 | Irvetan Tablet 100 mg |
| 2008-700071 (■) | 3162626 | Irbetan Tablets 100 mg (Active Ingredient: Irbesartan) |
| 2008-700070 (○) | 3162626 | Irbetan Tablet 50 mg |
| 2008-700070 (■) | 3162626 | Irbetan Tablets 50 mg (Active Ingredient: Irbesartan) |
| 2008-700069 (○) | 2868313 | Avapro Tablet 100 mg |
| 2008-700069 (■) | 2868313 | Avapro Tablet 100 mg (active ingredient: irbesartan) |
| 2008-700068 (○) | 2868313 | Avapro Tablet 50 mg |
| 2008-700068 (■) | 2868313 | Avapro 50 mg (active ingredient: irbesartan) |
| 2008-700067 (○) | 2868313 | Irvetan Tablet 100 mg |
| 2008-700067 (■) | 2868313 | Irbesartan |
| 2008-700066 (○) | 2868313 | Irbetan Tablet 50 mg |
| 2008-700066 (■) | 2868313 | Irbesartan |
| 2008-700065 (○) | 3702274 | Tocilizumab (genetically modified) |
| 2008-700065 (■) | 3702274 | Tocilizumab (genetically modified) |
| 2008-700064 (○) | 3370324 | Tocilizumab (genetically modified) |
| 2008-700064 (■) | 3370324 | Tocilizumab (genetically modified) |
| 2008-700063 (○) | 3702274 | Tocilizumab (genetically modified) |
| 2008-700063 (■) | 3702274 | Tocilizumab (genetically modified) |
| 2008-700062 (○) | 3370324 | Tocilizumab (genetically modified) |
| 2008-700062 (■) | 3370324 | Tocilizumab (genetically modified) |
| 2008-700061 (○) | 3067987 | Tocilizumab (genetically modified) |
| 2008-700061 (■) | 3067987 | Tocilizumab (genetically modified) |
| 2008-700060 (○) | 3370324 | Tocilizumab (genetically modified) |
| 2008-700060 (■) | 3370324 | Tocilizumab (genetically modified) |
| 2008-700059 (○) | 2998976 | Tocilizumab (genetically modified) |
| 2008-700058 (○) | 2042892 | General Name: Metconazole Chemical Name: (1RS, 5RS; 1RS, 5SR) -5- (4-Chlorobenzyl) -2,2-dimethyl-1- (1H-1,2,4-triazole-1 Ylmethyl) cyclopentanol |
| 2008-700058 (■) | 2042892 | General Name: Metconazole Chemical Name: (1RS, 5RS; 1RS, 5SR) -5- (4-Chlorobenzyl) -2,2-dimethyl-1- (1H-1,2,4-triazole-1 Ylmethyl) cyclopentanol |
| 2008-700057 (○) | 3926416 | (1RS, 5RS; 1RS, 5SR) -5- (4-chlorobenzyl) -2,2-dimethyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentanol |
| 2008-700056 (○) | 3663382 | Sunitinib malate |
| 2008-700056 (■) | 3663382 | Sunitinib malate |
| 2008-700055 (○) | 3861118 | Active ingredient: Adalimumab (genetically modified) Product Name: Humira Subcutaneous injection 40 mg Syringe 0.8 mL |
| 2008-700055 (■) | 3861118 | Active ingredient: Adalimumab (genetically modified) |
| 2008-700054 (○) | 3040121 | Trastuzumab (genetically modified) |
| 2008-700054 (■) | 3040121 | Trastuzumab (genetically modified) |
| 2008-700053 (○) | 3986085 | General name: ethiprole Chemical name: 5-amino-1- (2,6-dichloro-α, α, α-trifluoro-p-tolyl) -4-ethylsulfinylpyrazole-3-carbonitrile |
| 2008-700053 (■) | 3986085 | General name: ethiprole Chemical name: 5-amino-1- (2,6-dichloro-α, α, α-trifluoro-p-tolyl) -4-ethylsulfinylpyrazole-3-carbonitrile |
| 2008-700052 (○) | 3845792 | Sorafenib tosylate (brand name: Nexavar tablet 200 mg) |
| 2008-700052 (■) | 3845792 | Sorafenib tosylate |
| 2008-700051 (○) | 2501385 | Common name: montelukast sodium |
| 2008-700051 (■) | 2501385 | Common name: montelukast sodium |
| 2008-700050 (○) | 2501385 | Common name: montelukast sodium |
| 2008-700050 (■) | 2501385 | Common name: montelukast sodium |
| 2008-700049 (○) | 3640962 | Common name: montelukast sodium |
| 2008-700049 (■) | 3640962 | Common name: montelukast sodium |
| 2008-700048 (○) | 3640962 | Common name: montelukast sodium |
| 2008-700048 (■) | 3640962 | Common name: montelukast sodium |
| 2008-700047 (○) | 3095175 | Ibrituzumab Tiuxetane stock solution Indium chloride (111In) stock solution |
| 2008-700047 (■) | 3095175 | Ibrituzumab Tiuxetane stock solution Indium chloride (111In) stock solution |
| 2008-700046 (○) | 3095175 | Ibrituzumab Chiuxetane stock solution Yttrium chloride (90Y) |
| 2008-700046 (■) | 3095175 | Ibrituzumab Tiuxetane stock solution Yttrium chloride (90Y) |
| 2008-700045 (○) | 3095175 | Rituximab (genetically modified) |
| 2008-700045 (■) | 3095175 | i) Name of sale: Rituxan injection 10 mg / mL ii) Active ingredient: Rituximab (genetically modified) |
| 2008-700044 (○) | 3793583 | Sitafloxacin |
| 2008-700044 (■) | 3793583 | Sitafloxacin hydrate |
| 2008-700043 (○) | 2931458 | Sitafloxacin |
| 2008-700043 (■) | 2931458 | Sitafloxacin |
| 2008-700042 (○) | 2903292 | Sitafloxacin |
| 2008-700042 (■) | 2903292 | Sitafloxacin |
| 2008-700041 (○) | 2714597 | Sitafloxacin |
| 2008-700041 (■) | 2714597 | Sitafloxacin |
| 2008-700040 (○) | 2536248 | Tacrolimus hydrate |
| 2008-700040 (■) | 2536248 | Tacrolimus hydrate |
| 2008-700039 (○) | 3721021 | Sildenafil citrate |
| 2008-700038 (○) | 2866841 | Sildenafil citrate |
| 2008-700037 (○) | 2087736 | Sildenafil citrate |
| 2008-700037 (■) | 2087736 | Sildenafil citrate |
| 2008-700036 (○) | 3779682 | Varenicline tartrate |
| 2008-700036 (■) | 3779682 | Varenicline tartrate |
| 2008-700035 (○) | 3550359 | Varenicline tartrate |
| 2008-700035 (■) | 3550359 | Varenicline tartrate |
| 2008-700034 (○) | 2021373 | Blonanserin |
| 2008-700034 (■) | 2021373 | Blonanserin |
| 2008-700033 (○) | 3113078 | 3-mesityl-2-oxo-1-oxaspiro [4.4] non-3-en-4-yl = 3,3-dimethyl butyrate |
| 2008-700033 (■) | 3113078 | 3-mesityl-2-oxo-1-oxaspiro [4.4] non-3-en-4-yl = 3,3-dimethyl butyrate |
| 2008-700032 (○) | 3113078 | 3-mesityl-2-oxo-1-oxaspiro [4.4] non-3-en-4-yl = 3,3-dimethyl butyrate |
| 2008-700031 (○) | 3007785 | Thrombomodulin alpha (genetically modified) |
| 2008-700031 (■) | 3007785 | Thrombomodulin alpha (genetically modified) |
| 2008-700030 (○) | 2501297 | Capecitabine |
| 2008-700030 (■) | 2501297 | Capecitabine |
| 2008-700029 (○) | 1951556 | Capecitabine |
| 2008-700029 (■) | 1951556 | Capecitabine |
| 2008-700028 (○) | 2994182 | Flonicamid |
| 2008-700028 (■) | 2994182 | Flonicamid |
| 2008-700027 (○) | 3657002 | Darunavir ethanol adduct |
| 2008-700027 (■) | 3657002 | Darunavir ethanol adduct |
| 2008-700026 (○) | 1911883 | Naratriptan hydrochloride |
| 2008-700026 (■) | 1911883 | Naratriptan hydrochloride |
| 2008-700025 (○) | 2508949 | Nateglinide |
| 2008-700025 (■) | 2508949 | Nateglinide |
| 2008-700024 (○) | 2042892 | General Name: Metconazole Chemical Name: (1 RS, 5 RS; 1 RS, 5 SR) -5- (4-Chlorobenzyl) -2,2-dimethyl-1- <1> 1, 1- 1,4-triazole 1-ylmethyl) cyclopentanol |
| 2008-700024 (■) | 2042892 | General Name: Metconazole Chemical Name: (1 RS, 5 RS; 1 RS, 5 SR) -5- (4-Chlorobenzyl) -2,2-dimethyl-1- <1> 1, 1- 1,4-triazole 1-ylmethyl) cyclopentanol |
| 2008-700023 (○) | 2042892 | General Name: Metconazole Chemical Name: (1 RS, 5 RS; 1 RS, 5 SR) -5- (4-Chlorobenzyl) -2,2-dimethyl-1- <1> 1, 1- 1,4-triazole 1-ylmethyl) cyclopentanol |
| 2008-700023 (■) | 2042892 | General Name: Metconazole Chemical Name: (1 RS, 5 RS; 1 RS, 5 SR) -5- (4-Chlorobenzyl) -2,2-dimethyl-1- <1> 1, 1- 1,4-triazole 1-ylmethyl) cyclopentanol |
| 2008-700022 (○) | 3926416 | (1RS, 5RS; 1RS, 5SR) -5- (4-chlorobenzyl) -2,2-dimethyl-1- 1H-1,2,4-triazol-1-ylmethyl) cyclopentanol |
| 2008-700021 (○) | 3579430 | Human serum albumin (genetically modified) |
| 2008-700020 (○) | 3579430 | Human serum albumin (genetically modified) |
| 2008-700020 (■) | 3579430 | Medway injection 25%, human serum albumin (genetically modified) |
| 2008-700019 (○) | 3572483 | 2-methoxyethyl = (RS) -2- (4-tert-butylphenyl) -2-cyano-3-oxo-3- (α, α, α, -trifluoro o-tolyl) propionate |
| 2008-700019 (■) | 3572483 | 2-methoxyethyl = (RS) -2- (4-tert-butylphenyl) -2-cyano-3-oxo-3- (α, α, α-trifluor o-tolyl) propionate |
| 2008-700018 (○) | 3744941 | Pulmonary arterial hypertension |
| 2008-700018 (■) | 3744941 | Beraprost sodium |
| 2008-700017 (○) | 2042892 | General Name: Metconazole Chemical Name: (1 RS, 5 RS; 1 RS, 5 SR) -5- (4-Chlorobenzyl) -2,2-dimethyl-1- <1> 1, 1- 1,4-triazole 1-ylmethyl) cyclopentanol |
| 2008-700017 (■) | 2042892 | General Name: Metconazole Chemical Name: (1 RS, 5 RS; 1 RS, 5 SR) -5- (4-Chlorobenzyl) -2,2-dimethyl-1- <1> 1, 1- 1,4-triazole 1-ylmethyl) cyclopentanol |
| 2008-700016 (○) | 3996191 | Common name Th2 chemokine / TARC kit Product Name: Araport TARC |
| 2008-700016 (■) | 3996191 | General name: Mouse anti-human TARC monoclonal antibody solid phase well, peroxidase labeled mouse anti-human TARC monoclonal antibody, 2,2'-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium and hydrogen peroxide %) (Product Name: Alaport TARC |
| 2008-700015 (○) | 3881640 | Name of sale: Claritin dry syrup 1% Active ingredient: Loratadine (general name) |
| 2008-700015 (■) | 3881640 | Name of Sale: Claritin Dry Syrup 1% Active Ingredient: Loratadine |
| 2008-700014 (○) | 3420549 | Erlotinib hydrochloride (common name) |
| 2008-700014 (■) | 3420549 | Erlotinib hydrochloride (common name) |
| 2008-700013 (○) | 3088018 | Erlotinib hydrochloride (common name) |
| 2008-700013 (■) | 3088018 | Erlotinib hydrochloride (common name) |
| 2008-700012 (○) | 3840674 | Medway injection 25% |
| 2008-700012 (■) | 3840674 | Medway injection 25%, human serum albumin (genetically modified) |
| 2008-700011 (○) | 3533687 | Medway injection 25% |
| 2008-700011 (■) | 3533687 | Medway injection 25%, human serum albumin (genetically modified) |
| 2008-700010 (○) | 3508149 | Medway injection 25% |
| 2008-700010 (■) | 3508149 | Medway injection 25%, human serum albumin (genetically modified) |
| 2008-700009 (○) | 1953732 | Medway injection 25% |
| 2008-700009 (■) | 1953732 | Medway injection 25%, human serum albumin (genetically modified) |
| 2008-700008 (○) | 2080000 | Medway injection 25% |
| 2008-700008 (■) | 2080000 | Medway injection 25%, human serum albumin (genetically modified) |
| 2008-700007 (○) | 2093438 | Medway injection 25% |
| 2008-700007 (■) | 2093438 | Medway injection 25%, human serum albumin (genetically modified) |
| 2008-700006 (○) | 3014764 | Insulin detemir (genetically modified) |
| 2008-700006 (■) | 3014764 | Insulin detemir (genetically modified) |
| 2008-700005 (○) | 3014764 | Insulin detemir (genetically modified) |
| 2008-700005 (■) | 3014764 | Insulin detemir (genetically modified) |
| 2008-700004 (○) | 2603357 | Name of sale: EOB / Primovist injection syringe The syringe (syringe) is filled with the contrast agent (injection solution) of this patent used for imaging a liver tumor, the contrast agent (injection solution) ) Contains the general name of the present patent: sodium gadoxetic acid as an active ingredient. ) |
| 2008-700004 (■) | 2603357 | Gadoxetate sodium |
| 2008-700003 (○) | 2882882 | Cinacalcet hydrochloride (trade name: Regpara Tablet 25 mg) |
| 2008-700003 (■) | 2882882 | Cinacalcet hydrochloride (trade name: Regpara Tablet 25 mg) |
| 2008-700002 (○) | 2860285 | Cinacalcet hydrochloride (trade name: Regpara Tablet 25 mg) |
| 2008-700002 (■) | 2860285 | Cinacalcet hydrochloride (trade name: Regpara Tablet 25 mg) |
| 2008-700001 (○) | 2728564 | Cinacalcet hydrochloride (trade name: Regpara Tablet 25 mg) |
| 2008-700001 (■) | 2728564 | Cinacalcet hydrochloride (trade name: Regpara Tablet 25 mg) |
| 2007-700131 (○) | 3699223 | Hydroxocobalamin |
| 2007-700131 (■) | 3699223 | Hydroxocobalamin |
| 2007-700130 (○) | 3896002 | Clopidogrel sulfate |
| 2007-700130 (■) | 3896002 | Clopidogrel sulfate |
| 2007-700129 (○) | 3827946 | Clopidogrel sulfate |
| 2007-700129 (■) | 3827946 | Clopidogrel sulfate |
| 2007-700128 (○) | 3641584 | Clopidogrel sulfate |
| 2007-700128 (■) | 3641584 | Clopidogrel sulfate |
| 2007-700127 (○) | 3397385 | Clopidogrel sulfate |
| 2007-700127 (■) | 3397385 | Clopidogrel sulfate |
| 2007-700126 (○) | 3055819 | Clopidogrel sulfate |
| 2007-700126 (■) | 3055819 | Clopidogrel sulfate |
| 2007-700125 (○) | 2949366 | Clopidogrel sulfate |
| 2007-700125 (■) | 2949366 | Clopidogrel sulfate |
| 2007-700124 (○) | 2945174 | Clopidogrel sulfate |
| 2007-700124 (■) | 2945174 | Clopidogrel sulfate |
| 2007-700123 (○) | 2606720 | Cyazofamid |
| 2007-700123 (■) | 2606720 | Cyazofamid |
| 2007-700122 (○) | 2873086 | Nelarabine |
| 2007-700122 (■) | 2873086 | Nelarabine |
| 2007-700121 (○) | 2667873 | Nelarabine |
| 2007-700121 (■) | 2667873 | Nelarabine |
| 2007-700120 (○) | 3705518 | Donepezil hydrochloride |
| 2007-700120 (■) | 3705518 | Donepezil hydrochloride |
| 2007-700119 (○) | 3705518 | Donepezil hydrochloride |
| 2007-700119 (■) | 3705518 | Donepezil hydrochloride |
| 2007-700118 (○) | 3705518 | Donepezil hydrochloride |
| 2007-700118 (■) | 3705518 | Donepezil hydrochloride |
| 2007-700117 (○) | 2578475 | Donepezil hydrochloride |
| 2007-700117 (■) | 2578475 | Donepezil hydrochloride |
| 2007-700116 (○) | 2578475 | Donepezil hydrochloride |
| 2007-700116 (■) | 2578475 | Donepezil hydrochloride |
| 2007-700115 (○) | 2578475 | Donepezil hydrochloride |
| 2007-700115 (■) | 2578475 | Donepezil hydrochloride |
| 2007-700114 (○) | 2578475 | Donepezil hydrochloride |
| 2007-700114 (■) | 2578475 | Donepezil hydrochloride |
| 2007-700113 (○) | 2578475 | Donepezil hydrochloride |
| 2007-700113 (■) | 2578475 | Donepezil hydrochloride |
| 2007-700112 (○) | 2578475 | Donepezil hydrochloride |
| 2007-700112 (■) | 2578475 | Donepezil hydrochloride |
| 2007-700111 (○) | 2578475 | Donepezil hydrochloride |
| 2007-700111 (■) | 2578475 | Donepezil hydrochloride |
| 2007-700110 (○) | 3752077 | Tegafur, Guimeracil and Oteracil Potassium (Product Name: TS-1 Capsule 25) |
| 2007-700110 (■) | 3752077 | Tegafur, Guimeracil and Oteracil Potassium (Product Name: TS-1 Capsule 25) |
| 2007-700109 (○) | 3113078 | 3- (2,4-Dichlorophenyl) -2-oxo-1-oxas pyro [4.5] dec-3-en-4-yl = 2,2-dimethyl butyrate |
| 2007-700109 (■) | 3113078 | 3- (2,4-Dichlorophenyl) -2-oxo-1-oxaspiro [4.5] dec-3-en-4-yl = 2,2-dimethyl butyrate |
| 2007-700108 (○) | 3000240 | Methyl = (E) -methoxyimino-{(E) -α- [1- (α, α, α-trifluoro-m-tolyl) ethylideneaminooxy] -o-tolyl} acetate |
| 2007-700108 (■) | 3000240 | Methyl = (E) -methoxyimino-{(E) -α- [1- (α, α, α-trifluoro-m-tolyl) ethylideneaminooxy] -o-tolyl} acetate |
| 2007-700107 (○) | 3168582 | Active ingredients: Isopropyl antipyrine Ibuprofen Anhydrous caffeine |
| 2007-700107 (■) | 3168582 | Active Ingredients: Isopropyl Antipyrine Ibuprofen Anhydrous Caffeine |
| 2007-700106 (○) | 2538422 | Tegafur, gimeracil and oteracil potassium (brand name: TS-1 capsule 25) |
| 2007-700106 (■) | 2538422 | Tegafur, Guimeracil and Oteracil Potassium (Product Name: TS-1 Capsule 25) |
| 2007-700105 (○) | 2614164 | Degafur, Guimeracil and Oteracil Potassium (brand name: TS-1 capsule 25) |
| 2007-700105 (■) | 2614164 | Tegafur, Guimeracil and Oteracil Potassium (Product Name: TS-1 Capsule 25) |
| 2007-700104 (○) | 3808095 | Tadarafil |
| 2007-700104 (■) | 3808095 | Tadarafil |
| 2007-700103 (○) | 3808095 | Tadarafil |
| 2007-700103 (■) | 3808095 | Tadarafil |
| 2007-700102 (○) | 3808095 | Tadarafil |
| 2007-700102 (■) | 3808095 | Tadarafil |
| 2007-700101 (○) | 2915034 | Vecella cream 5% (active ingredient: imiquimod) |
| 2007-700101 (■) | 2915034 | Vecella cream 5% (active ingredient: imiquimod) |
| 2007-700100 (○) | 3926416 | (1RS, 5RS; 1RS, 5SR) -5- (4-chlorobenzyl) -2,2-dimethyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentanol |
| 2007-700099 (○) | 1898119 | General Name: Metconazole Chemical Name: (1 RS, 5 RS; 1 RS, 5 SR) -5- (4-Chlorobenzyl) -2,2-dimethyl-1- <1> 1, 1- 1,4-triazole 1-ylmethyl) cyclopentanol |
| 2007-700099 (■) | 1898119 | General Name: Metconazole Chemical Name: (1 RS, 5 RS; 1 RS, 5 SR) -5- (4-Chlorobenzyl) -2,2-dimethyl-1- <1> 1, 1- 1,4-triazole 1-ylmethyl) cyclopentanol |
| 2007-700098 (○) | 2994182 | Flonicamid |
| 2007-700098 (■) | 2994182 | Flonicamid |
| 2007-700097 (○) | 2606720 | Cyazofamid |
| 2007-700097 (■) | 2606720 | Cyazofamid |
| 2007-700096 (○) | 2032916 | Eslax IV 1% |
| 2007-700096 (■) | 2032916 | Eslax IV 1% |
| 2007-700095 (○) | 2042892 | General Name: Metconazole Chemical Name: (1 RS, 5 RS; 1 RS, 5 SR) -5- (4-Chlorobenzyl) -2,2-dimethyl-1- <1> 1, 1- 1,4-triazole 1-ylmethyl) cyclopentanol |
| 2007-700095 (■) | 2042892 | General Name: Metconazole Chemical Name: (1 RS, 5 RS; 1 RS, 5 SR) -5- (4-Chlorobenzyl) -2,2-dimethyl-1- <1> 1, 1- 1,4-triazole 1-ylmethyl) cyclopentanol |
| 2007-700094 (○) | 2037587 | Rabeprazole sodium |
| 2007-700093 (○) | 2010529 | Rabeprazole sodium |
| 2007-700092 (○) | 3531880 | Active ingredient of pharmaceuticals targeted for disposal Ferrovacs FIV (general name) |
| 2007-700091 (○) | 3281872 | Galenoxacin Mesilate Hydrate |
| 2007-700090 (○) | 3031722 | Galenoxacin Mesilate Hydrate |
| 2007-700089 (○) | 2994759 | Galenoxacin Mesilate Hydrate |
| 2007-700088 (○) | 3281872 | Galenoxacin Mesilate Hydrate |
| 2007-700088 (■) | 3281872 | Galenoxacin Mesilate Hydrate |
| 2007-700087 (○) | 3031722 | Galenoxacin Mesilate Hydrate |
| 2007-700087 (■) | 3031722 | Galenoxacin Mesilate Hydrate |
| 2007-700086 (○) | 2994759 | Galenoxacin Mesilate Hydrate |
| 2007-700086 (■) | 2994759 | Galenoxacin Mesilate Hydrate |
| 2007-700085 (○) | 2686863 | Mitiglinide calcium hydrate |
| 2007-700085 (■) | 2686863 | Mitiglinide calcium hydrate |
| 2007-700084 (○) | 2686863 | Mitiglinide calcium hydrate |
| 2007-700084 (■) | 2686863 | Mitiglinide calcium hydrate |
| 2007-700083 (○) | 3535436 | Porcine testicular cell line inactivated pig parvovirus NADL-7 strain Pig epidemic CN3342 strain culture supernatant concentrate inactivated Leptospira interrogans serotype Bratislava JEZ type inactivated Leptospira interrogans serotype Canicola C-51 strain inactivated Leptospira interrogans serotype Glippophysa MAL 1540 strain inactivated Leptospira interrogans serotype Hario WHO strain inactivated Leptospira interrogans serotype Ikterohemozyme NADL 11403 strain Inactivated Leptospira interrogans serotype Pomona T262 strain |
| 2007-700083 (■) | 3535436 | Porcine testicular cell culture inactivated inactivated porcine parvovirus NADL-7 strain E. teratocarcinus CN3342 strain culture supernatant fresh liquid concentrate inactivated Leptospira ・ interogans serotype Bratislava JEZ inactivated inverted lep Thospira interrogans serum Type Cyancola C-51 strain inactivated Leptospira interrogans serotype Glippophysa MAL 1540 strain inactivated Leptospira interrogans serotype Hario WHO strain inactivation Leptospira interrogans serotype Ikterohemologus strain NADL 11403 inactivation Leptospira interrogans serotype Pomona T262 strain |
| 2007-700082 (○) | 2851428 | Convener injection (general name: cefobecin sodium for injection) |
| 2007-700082 (■) | 2851428 | CONVENIOR injection (common name cefobecin sodium for injection) |
| 2007-700081 (○) | 3734090 | Ciclesonide |
| 2007-700081 (■) | 3734090 | Ciclesonide |
| 2007-700080 (○) | 3807509 | Ciclesonide |
| 2007-700080 (■) | 3807509 | Ciclesonide |
| 2007-700079 (○) | 3725783 | Carteolol hydrochloride and alginic acid |
| 2007-700079 (■) | 3725783 | Carteolol hydrochloride, Michelin LA eye drops 1% |
| 2007-700078 (○) | 3398382 | Bevacizumab (genetically modified) |
| 2007-700078 (■) | 3398382 | Bevacizumab (genetically modified) |
| 2007-700077 (○) | 3333210 | Ciclecinide |
| 2007-700077 (■) | 3333210 | Ciclecinide |
| 2007-700076 (○) | 3292928 | Ciclesonide |
| 2007-700076 (■) | 3292928 | Ciclesonide |
| 2007-700075 (○) | 3176633 | Baracyclovir hydrochloride |
| 2007-700074 (○) | 1930741 | Baracyclovir hydrochloride |
| 2007-700074 (■) | 1930741 | Baracyclovir hydrochloride |
| 2007-700073 (○) | 3679715 | Common name: Ezetimibe |
| 2007-700073 (■) | 3679715 | Common name: Ezetimibe |
| 2007-700072 (○) | 3640888 | Common name: Ezetimibe |
| 2007-700072 (■) | 3640888 | Common name: Ezetimibe |
| 2007-700071 (○) | 3155759 | Common name: Ezetimibe |
| 2007-700071 (■) | 3155759 | Common name: Ezetimibe |
| 2007-700070 (○) | 2840452 | Common name: Ezetimibe |
| 2007-700070 (■) | 2840452 | Common name: Ezetimibe |
| 2007-700069 (○) | 3042867 | Salmeterol xinafoate and fluticasone propionate |
| 2007-700069 (■) | 3042867 | Salmeterol xinafoate and fluticasone propionate |
| 2007-700068 (○) | 3053503 | Picormi ucOC |
| 2007-700068 (■) | 3053503 | Anti-GluOC4-5 mouse monoclonal antibody conjugated beads and ruthenium labeled anti-OCG3 mouse monoclonal antibody |
| 2007-700067 (○) | 3294961 | Common Name: Imidafenacin |
| 2007-700067 (■) | 3294961 | Common Name: Imidafenacin |
| 2007-700066 (○) | 3294961 | Common Name: Imidafenacin |
| 2007-700066 (■) | 3294961 | Common Name: Imidafenacin |
| 2007-700065 (○) | 3294961 | Common Name: Imidafenacin |
| 2007-700065 (■) | 3294961 | Common Name: Imidafenacin |
| 2007-700064 (○) | 3073905 | Darbepoetin alpha (genetically modified) |
| 2007-700064 (■) | 3073905 | Darbepoetin alpha (genetically modified) |
| 2007-700063 (○) | 2938572 | Darbepoetin alpha (genetically modified) |
| 2007-700063 (■) | 2938572 | Darbepoetin alpha (genetically modified) |
| 2007-700062 (○) | 3000240 | Methyl = (E) -methoxyimino-{(E) -α- [1- (α, α, α-trifluoro-m-tolyl) ethylideneaminooxy] -o-tolyl} acetate |
| 2007-700062 (■) | 3000240 | Methyl = (E) -methoxyimino-{(E) -α- [1- (α, α, α-trifluoro-m-tolyl) ethylideneaminooxy] -o-tolyl acetate |
| 2007-700061 (○) | 2042892 | General Name: Metconazole Chemical Name: (1RS, 5RS; 1RS, 5SR) -5- (4-Chlorobenzyl) -2,2-dimethyl-1- (1H-1,2,4-triazole-1 Ylmethyl) cyclopentanol |
| 2007-700060 (○) | 3810610 | Urso Tablet 100 mg |
| 2007-700060 (■) | 3810610 | Ursodeoxycholic acid |
| 2007-700059 (○) | 3810610 | Urso Tablet 50 mg |
| 2007-700059 (■) | 3810610 | Ursodeoxycholic acid |
| 2007-700058 (○) | 2948315 | Name of sale: Carbostar dialysate, P |
| 2007-700058 (■) | 2948315 | Name of sale: Carbostar dialysate, P |
| 2007-700057 (○) | 2803908 | Common name: Ezetimibe |
| 2007-700057 (■) | 2803908 | Common name: Ezetimibe |
| 2007-700056 (○) | 2994182 | Flonicamid |
| 2007-700056 (■) | 2994182 | Flonicamid |
| 2007-700055 (○) | 3117462 | Everolimus |
| 2007-700055 (■) | 3117462 | Everolimus |
| 2007-700054 (○) | 3789928 | Peg bisomant |
| 2007-700053 (○) | 3628333 | Peg bisomant |
| 2007-700053 (■) | 3628333 | Peg bisomant |
| 2007-700052 (○) | 2823680 | General name: Entacapone Chemical name: (2E) -2-cyano-3- (3,4-dihydroxy-5-nitrophenyl) -N, N-diethylprop-2-enamide |
| 2007-700052 (■) | 2823680 | General name: Entacapone Chemical name: (2E) -2-Cyano-3- (3,4-dihydroxy-5-nitrophenyl) -N, N-diethylprop-2-enamide |
| 2007-700051 (○) | 2735834 | General name: Entacapone Chemical name: (2E) -2-cyano-3- (3,4-dihydroxy-5-nitrophenyl) -N, N-diethylprop-2-enamide |
| 2007-700051 (■) | 2735834 | General name: Entacapone Chemical name: (2E) -2-Cyano-3- (3,4-dihydroxy-5-nitrophenyl) -N, N-diethylprop-2-enamide |
| 2007-700050 (○) | 1898119 | General Name: Metconazole Chemical Name: (1 RS, 5 RS; 1 RS, 5 SR) -5- (4-Chlorobenzyl) -2,2-dimethyl-1- <1> 1, 1- 1,4-triazole 1-ylmethyl) cyclopentanol |
| 2007-700049 (○) | 3523870 | Fludarabine phosphate |
| 2007-700048 (○) | 3202234 | Fludarabine phosphate |
| 2007-700048 (■) | 3202234 | Fludarabine phosphate |
| 2007-700047 (○) | 2980569 | Peginterferon Alpha 2a (genetically modified) (brand name: Pegasis subcutaneously injected 180 μg) |
| 2007-700047 (■) | 2980569 | Peginterferon alfa 2a (genetically engineered) (Brand name: Pegasys subcutaneous injection 180 μg) |
| 2007-700046 (○) | 3839667 | Peginterferon Alpha 2a (genetically modified) (brand name: Pegasis subcutaneously injected 180 μg) |
| 2007-700046 (■) | 3839667 | Peginterferon alfa 2a (genetically engineered) (Brand name: Pegasys subcutaneous injection 180 μg) |
| 2007-700045 (○) | 3839667 | Ribavirin (brand name: Copegas Tablet 200 mg) |
| 2007-700045 (■) | 3839667 | Ribavirin (brand name: Copegas Tablets 200 mg) |
| 2007-700044 (○) | 3381722 | Micafungin sodium |
| 2007-700044 (■) | 3381722 | Micafungin sodium |
| 2007-700043 (○) | 2897427 | Micafungin sodium |
| 2007-700043 (■) | 2897427 | Micafungin sodium |
| 2007-700042 (○) | 3307410 | Micafungin sodium |
| 2007-700042 (■) | 3307410 | Micafungin sodium |
| 2007-700041 (○) | 3358024 | Flubenzamide Hydrate |
| 2007-700041 (■) | 3358024 | Flubendiamide |
| 2007-700040 (○) | 3317972 | Zanamivir Hydrate |
| 2007-700040 (■) | 3317972 | Zanamivir Hydrate |
| 2007-700039 (○) | 2944750 | Zanamivir Hydrate |
| 2007-700039 (■) | 2944750 | Zanamivir Hydrate |
| 2007-700038 (○) | 3563036 | Celecoxib |
| 2007-700038 (■) | 3563036 | Celecoxib |
| 2007-700037 (○) | 3563036 | Celecoxib |
| 2007-700036 (○) | 3025017 | Celecoxib |
| 2007-700036 (■) | 3025017 | Celecoxib |
| 2007-700035 (○) | 3025017 | Celecoxib |
| 2007-700035 (■) | 3025017 | Celecoxib |
| 2007-700034 (○) | 2889549 | Doxorubicin hydrochloride |
| 2007-700033 (○) | 3016876 | Pemetrexed sodium hydrate |
| 2007-700033 (■) | 3016876 | Pemetrexed sodium hydrate |
| 2007-700032 (○) | 2915146 | Modafinil |
| 2007-700032 (■) | 2915146 | Modafinil |
| 2007-700031 (○) | 2667051 | Doxorubicin hydrochloride |
| 2007-700030 (○) | 2659136 | Doxorubicin hydrochloride |
| 2007-700029 (○) | 1822561 | Tacrolimus |
| 2007-700029 (■) | 1822561 | Tacrolimus |
| 2007-700027 (○) | 2037587 | Rabeprazole sodium |
| 2007-700027 (■) | 2037587 | Rabeprazole sodium |
| 2007-700026 (○) | 2010529 | Rabeprazole sodium |
| 2007-700026 (■) | 2010529 | Rabeprazole sodium |
| 2007-700025 (○) | 1953321 | Rabeprazole sodium |
| 2007-700025 (■) | 1953321 | Rabeprazole sodium |
| 2007-700024 (○) | 2112593 | Emamectin benzoate / lufenuron wettable powder (general name) |
| 2007-700023 (○) | 2042892 | General Name: Metconazole Chemical Name: (1RS, 5RS; 1RS, 5SR) -5- (4-Chlorobenzyl) -2,2-dimethyl-1- (1H-1,2,4-triazole-1 Ylmethyl) cyclopentanol |
| 2007-700023 (■) | 2042892 | General Name: Metconazole Chemical Name: (1RS, 5RS; 1RS, 5SR) -5- (4-Chlorobenzyl) -2,2-dimethyl-1- (1H-1,2,4-triazole-1 Ylmethyl) cyclopentanol |
| 2007-700022 (○) | 2606720 | Cyazofamid |
| 2007-700022 (■) | 2606720 | Cyazofamid |
| 2007-700021 (○) | 1898119 | General Name: Metconazole Chemical Name: (1RS, 5RS; 1RS, 5SR) -5- (4-Chlorobenzyl) -2,2-dimethyl-1- (1H-1,2,4-triazole-1 Ylmethyl) cyclopentanol |
| 2007-700021 (■) | 1898119 | General Name: Metconazole Chemical Name: (1RS, 5RS; 1RS, 5SR) -5- (4-Chlorobenzyl) -2,2-dimethyl-1- (1H-1,2,4-triazole-1 Ylmethyl) cyclopentanol |
| 2007-700020 (○) | 2042892 | General Name: Metconazole Chemical Name: (1RS, 5RS; 1RS, 5SR) -5- (4-Chlorobenzyl) -2,2-dimethyl-1- (1H-1,2,4-triazole-1 Ylmethyl) cyclopentanol |
| 2007-700020 (■) | 2042892 | General Name: Metconazole Chemical Name: (1RS, 5RS; 1RS, 5SR) -5- (4-Chlorobenzyl) -2,2-dimethyl-1- (1H-1,2,4-triazole-1 Ylmethyl) cyclopentanol |
| 2007-700019 (○) | 1898119 | General Name: Metconazole Chemical Name: (1RS, 5RS; 1RS, 5SR) -5- (4-Chlorobenzyl) -2,2-dimethyl-1- (1H-1,2,4-triazole-1 Ylmethyl) cyclopentanol |
| 2007-700019 (■) | 1898119 | General name: Metconazole Chemical name: (1RS, 5RS; 1RS, 5SR) -5- (4-chlorobenzyl) -2,2-dimethyl-1- (1H-1, 2, 4-triazole-1 Ylmethyl) cyclopentanol |
| 2007-700018 (○) | 2035981 | Ropinirole hydrochloride |
| 2007-700018 (■) | 2035981 | Ropinirole hydrochloride |
| 2007-700017 (○) | 1974938 | Ropinirole hydrochloride |
| 2007-700017 (■) | 1974938 | Ropinirole hydrochloride |
| 2007-700016 (○) | 2035981 | Ropinirole hydrochloride |
| 2007-700016 (■) | 2035981 | Ropinirole hydrochloride |
| 2007-700015 (○) | 1974938 | Ropinirole hydrochloride |
| 2007-700015 (■) | 1974938 | Ropinirole chloride |
| 2007-700014 (○) | 2606720 | Cyazofamid TPN |
| 2007-700014 (■) | 2606720 | Cyazofamid TPN |
| 2007-700013 (○) | 2895145 | Remifenthal hydrochloride |
| 2007-700013 (■) | 2895145 | Remifenthal hydrochloride |
| 2007-700012 (○) | 3717934 | Bortezomib |
| 2007-700012 (■) | 3717934 | Bortezomib |
| 2007-700011 (○) | 2788548 | Ropinirole hydrochloride |
| 2007-700011 (■) | 2788548 | Ropinirole hydrochloride |
| 2007-700010 (○) | 1879525 | Ropinirole hydrochloride |
| 2007-700010 (■) | 1879525 | Ropinirole hydrochloride |
| 2007-700009 (○) | 2788548 | Ropinirole hydrochloride |
| 2007-700009 (■) | 2788548 | Ropinirole hydrochloride |
| 2007-700008 (○) | 1879525 | Ropinirole hydrochloride |
| 2007-700007 (○) | 3634869 | Active ingredient name: Perflubutane micro bubble |
| 2007-700007 (■) | 3634869 | Perflubutane micro bubble |
| 2007-700006 (○) | 3231768 | Active ingredient name: Perflubutane micro bubble |
| 2007-700006 (■) | 3231768 | Active ingredient name: Perflubutane micro bubble |
| 2007-700005 (○) | 3424927 | Active ingredient name: Perflubutane micro bubble |
| 2007-700005 (■) | 3424927 | Active ingredient name: Perflubutane micro bubble |
| 2007-700004 (○) | 3302647 | Landiolol hydrochloride |
| 2007-700004 (■) | 3302647 | Landiolol hydrochloride |
| 2007-700003 (○) | 2004651 | Landiolol hydrochloride |
| 2007-700003 (■) | 2004651 | Landiolol hydrochloride |
| 2007-700002 (○) | 3828648 | Lansoprazole |
| 2007-700002 (■) | 3828648 | Lansoprazole |
| 2007-700001 (○) | 1959606 | Lansoprazole |
| 2007-700001 (■) | 1959606 | Lansoprazole |
| 2006-700105 (○) | 2994182 | Flonicamid |
| 2006-700105 (■) | 2994182 | Flonicamid |
| 2006-700104 (○) | 2994182 | Flonicamid |
| 2006-700104 (■) | 2994182 | Flonicamid |
| 2006-700103 (○) | 3350055 | Baracyclovir hydrochloride |
| 2006-700102 (○) | 3176633 | Baracyclovir hydrochloride |
| 2006-700101 (○) | 3176633 | Baracyclovir hydrochloride |
| 2006-700100 (○) | 1930741 | Baracyclovir hydrochloride |
| 2006-700100 (■) | 1930741 | Baracyclovir hydrochloride |
| 2006-700099 (○) | 1930741 | Baracyclovir hydrochloride |
| 2006-700099 (■) | 1930741 | Baracyclovir hydrochloride |
| 2006-700098 (○) | 3599285 | Busulfan |
| 2006-700098 (■) | 3599285 | Busulfan |
| 2006-700095 (○) | 2614164 | Tegafur, Guimeracil and Oteracil Potassium (Product Name: TS-1 Capsule 25) |
| 2006-700095 (■) | 2614164 | Tegafur, Guimeracil and Oteracil Potassium (Product Name: TS-1 Capsule 25) |
| 2006-700094 (○) | 2538422 | Tegafur, Guimeracil and Oteracil Potassium (Product Name: TS-1 Capsule 25) |
| 2006-700094 (■) | 2538422 | Tegafur, Guimeracil and Oteracil Potassium (Product Name: TS-1 Capsule 25) |
| 2006-700093 (○) | 3113078 | 3- (2,4-Dichlorophenyl) -2-oxo-1-oxaspiro [4.5] dec-3-en-4-yl = 2,2-dimethyl butyrate |
| 2006-700093 (■) | 3113078 | 3- (2,4-Dichlorophenyl) -2-oxo-1-oxaspiro [4.5] dec-3-en-4-yl = 2,2-dimethyl butyrate |
| 2006-700092 (○) | 3261123 | Gabapentin |
| 2006-700092 (■) | 3261123 | Gabapentin |
| 2006-700091 (○) | 3261123 | Gabapentin (general name) |
| 2006-700091 (■) | 3261123 | Gabapentin (general name) |
| 2006-700090 (○) | 3148223 | Gabapentin |
| 2006-700090 (■) | 3148223 | Gabapentin |
| 2006-700089 (○) | 3148223 | Gabapentin (general name) |
| 2006-700088 (○) | 3599285 | 60 mg for busulfax infusion |
| 2006-700088 (■) | 3599285 | 60 mg for busulfax infusion |
| 2006-700087 (○) | 3527729 | Gabapentin |
| 2006-700087 (■) | 3527729 | Gabapentin |
| 2006-700086 (○) | 2994117 | Baraclude Tablets 0.5 mg |
| 2006-700086 (■) | 2994117 | Baraclude Tablets 0.5 mg |
| 2006-700085 (○) | 2771853 | Moxifloxacin hydrochloride |
| 2006-700085 (■) | 2771853 | Moxifloxacin hydrochloride |
| 2006-700084 (○) | 2905909 | Mozabaptan Hydrochloride (Name: Fizzulin Tablets 30 mg) |
| 2006-700084 (■) | 2905909 | Mozabaptan Hydrochloride (Name: Fizzulin Tablets 30 mg) |
| 2006-700083 (○) | 2052993 | Mozabaptan Hydrochloride (Name: Fizzulin Tablets 30 mg) |
| 2006-700083 (■) | 2052993 | Mozabaptan Hydrochloride (Name: Fizzulin Tablets 30 mg) |
| 2006-700082 (○) | 2052993 | Mozabaptan hydrochloride |
| 2006-700082 (■) | 2052993 | Mozabaptan hydrochloride |
| 2006-700081 (○) | 2653958 | Cyclosporin |
| 2006-700081 (■) | 2653958 | Cyclosporin |
| 2006-700080 (○) | 2653958 | Cyclosporin |
| 2006-700080 (■) | 2653958 | Cyclosporin |
| 2006-700079 (○) | 1996397 | Cyclosporin |
| 2006-700079 (■) | 1996397 | Cyclosporin |
| 2006-700078 (○) | 1996397 | Cyclosporin |
| 2006-700078 (■) | 1996397 | Cyclosporin |
| 2006-700077 (○) | 2820319 | Lansoprazole |
| 2006-700077 (■) | 2820319 | Lansoprazole |
| 2006-700076 (○) | 2874342 | Emodepsid & Prajquantel (Sale Name: Professional Fender Spot) |
| 2006-700076 (■) | 2874342 | Emodepsid and Prajquantel (brand name: pro fender spot) |
| 2006-700075 (○) | 3404648 | Lansoprazole |
| 2006-700075 (■) | 3404648 | Lansoprazole |
| 2006-700074 (○) | 3746167 | Lansoprazole |
| 2006-700074 (■) | 3746167 | Lansoprazole |
| 2006-700073 (○) | 2820829 | Lansoprazole |
| 2006-700073 (■) | 2820829 | Lansoprazole |
| 2006-700072 (○) | 2120237 | Lansoprazole |
| 2006-700072 (■) | 2120237 | Lansoprazole |
| 2006-700071 (○) | 1959606 | Lansoprazole |
| 2006-700071 (■) | 1959606 | Lansoprazole |
| 2006-700070 (○) | 1959606 | Lansoprazole |
| 2006-700070 (■) | 1959606 | Lansoprazole |
| 2006-700069 (○) | 2138026 | Lansoprazole |
| 2006-700068 (○) | 2138026 | Lansoprazole |
| 2006-700067 (○) | 2135990 | Lansoprazole |
| 2006-700066 (○) | 2135990 | Lansoprazole |
| 2006-700065 (○) | 1872737 | General name: Olopatadine hydrochloride Sales name: Patanol eye drop 0.1% Chemical name: · cis-11-(3-dimethylaminopropylidene)-6, 11-dihydrodibenz [b, e ] Oxepin-2-acetic acid hydrochloride (name described in the protocol of the protocol) The substances indicated by the above chemical names are identical substances. Chemical Structural Formula The above-mentioned common names, chemical names and chemical structural formulas indicate the same substances.In addition, Patanol eye drop 0.1% is an eye drop containing olopatadine hydrochloride. |
| 2006-700065 (■) | 1872737 | General name: Olopatadine hydrochloride Sales name: Patanol eye drop 0.1% Chemical name: · cis-11-(3-dimethylaminopropylidene)-6, 11-dihydrodibenz [b, e ] Oxepin-2-acetic acid hydrochloride (name described in the protocol of the protocol) The substances indicated by the above chemical names are identical substances. Chemical Structural Formula The above-mentioned common names, chemical names and chemical structural formulas indicate the same substances.In addition, Patanol eye drop 0.1% is an eye drop containing olopatadine hydrochloride. |
| 2006-700064 (○) | 3068858 | General name: Olopatadine hydrochloride Sales name: Patanol eye drop 0.1% Chemical name: · cis-11-(3-dimethylaminopropylidene)-6, 11-dihydrodibenz [b, e ] Oxepin-2-acetic acid hydrochloride (name described in the protocol of the protocol) The substances indicated by the above chemical names are identical substances. Chemical Structural Formulas The above-mentioned common names, chemical names and chemical structural formulas indicate the same substances.In addition, Patanol eye drop 0.1% is an eye drop containing olopatadine hydrochloride. |
| 2006-700064 (■) | 3068858 | General name: Olopatadine hydrochloride Sales name: Patanol eye drop 0.1% Chemical name: · cis-11-(3-dimethylaminopropylidene)-6, 11-dihydrodibenz [b, e ] Oxepin-2-acetic acid hydrochloride (name described in the protocol of the protocol) The substances indicated by the above chemical names are identical substances. Chemical Structural Formula The above-mentioned common names, chemical names and chemical structural formulas indicate the same substances.In addition, Patanol eye drop 0.1% is an eye drop containing olopatadine hydrochloride. |
| 2006-700063 (○) | 2081261 | General name: Olopatadine hydrochloride Sales name: Patanol eye drop 0.1% Chemical name: · cis-11-(3-dimethylaminopropylidene)-6, 11-dihydrodibenz [b, e ] Oxepin-2-acetic acid hydrochloride (name described in the protocol of the protocol) The substances indicated by the above chemical names are identical substances. Chemical Structural Formula The above-mentioned common names, chemical names and chemical structural formulas indicate the same substances.In addition, Patanol eye drop 0.1% is an eye drop containing olopatadine hydrochloride. |
| 2006-700063 (■) | 2081261 | General name: Olopatadine hydrochloride Sales name: Patanol eye drop 0.1% Chemical name: · cis-11-(3-dimethylaminopropylidene)-6, 11-dihydrodibenz [b, e ] Oxepin-2-acetic acid hydrochloride (name described in the protocol of the clinical trial plan) It is the same substance. Chemical structural formula The above-mentioned common name, chemical name and chemical structural formula are the same substance and 0.1% of Patanol ophthalmic solution is olopatadine hydrochloride It is an eye drop that containsdimethylamino) propylidene] -6,11-dihydro |
| 2006-700062 (○) | 3068033 | Epoetin beta (genetically modified) (general name) |
| 2006-700062 (■) | 3068033 | Epoetin beta (genetically modified) (general name) |
| 2006-700061 (○) | 2958774 | Name of sale: Ambisome 50 mg for intravenous infusion |
| 2006-700061 (■) | 2958774 | Name of sale: Ambisome 50 mg for intravenous infusion |
| 2006-700060 (○) | 1890276 | Name of sale: Ambisome 50 mg for intravenous infusion |
| 2006-700060 (■) | 1890276 | Name of sale: Ambisome 50 mg for intravenous infusion |
| 2006-700059 (■) | 3439855 | Cetrorelix acetate |
| 2006-700056 (○) | 2911674 | Cetrorelix acetate |
| 2006-700055 (○) | 3533179 | Sertraline hydrochloride |
| 2006-700054 (○) | 3533179 | Sertraline hydrochloride |
| 2006-700053 (○) | 3616011 | Tolterodine tartrate |
| 2006-700053 (■) | 3616011 | Tolterodine tartrate |
| 2006-700052 (○) | 2664503 | Tolterodine tartrate |
| 2006-700052 (■) | 2664503 | Tolterodine tartrate |
| 2006-700051 (○) | 2944669 | Cetrorelix acetate |
| 2006-700051 (■) | 2944669 | Cetrorelix acetate |
| 2006-700050 (○) | 3176630 | Linezolid |
| 2006-700050 (■) | 3176630 | Linezolid |
| 2006-700049 (○) | 3176630 | Linezolid |
| 2006-700049 (■) | 3176630 | Linezolid |
| 2006-700048 (■) | 1819199 | Common Name: Losartan Potassium |
| 2006-700047 (■) | 1819199 | Common Name: Losartan Potassium |
| 2006-700046 (■) | 3014457 | Solifenacin succinate |
| 2006-700045 (■) | 3014457 | Solifenacin succinate |
| 2006-700044 (○) | 2606720 | Cyazofamid |
| 2006-700043 (○) | 2008845 | Levofloxacin |
| 2006-700043 (■) | 2008845 | Levofloxacin |
| 2006-700042 (○) | 1659502 | Levofloxacin |
| 2006-700042 (■) | 1659502 | Levofloxacin |
| 2006-700041 (○) | 2606720 | Cyazofamid |
| 2006-700041 (■) | 2606720 | Cyazofamid |
| 2006-700040 (○) | 2523843 | Gonard-f150 subcutaneous injection (brand name) |
| 2006-700040 (■) | 2523843 | Holitropin alpha (genetically engineered) |
| 2006-700039 (○) | 2523843 | Gonard-f75 subcutaneous injection (brand name) |
| 2006-700039 (■) | 2523843 | Holitropin alpha (genetically engineered) |
| 2006-700038 (○) | 3750023 | Aripiprazole (Sale name: Evilify 1%) |
| 2006-700038 (■) | 3750023 | Aripiprazole |
| 2006-700037 (○) | 3750023 | Aripiprazole (Sale Name: Aripiprazole) |
| 2006-700037 (■) | 3750023 | Aripiprazole |
| 2006-700036 (○) | 3760264 | Aripiprazole (Sale name: Evilify 1%) |
| 2006-700036 (■) | 3760264 | Aripiprazole |
| 2006-700035 (○) | 3760264 | Aripiprazole (Sale Name: Aripiprazole) |
| 2006-700035 (■) | 3760264 | Aripiprazole |
| 2006-700034 (○) | 2608788 | Aripiprazole (Sale name: Evilify 1%) |
| 2006-700034 (■) | 2608788 | Aripiprazole |
| 2006-700033 (○) | 2987484 | Aripiprazole (Sale name: Evilify 1%) |
| 2006-700033 (■) | 2987484 | Aripiprazole |
| 2006-700032 (○) | 2987484 | Aripiprazole (Sale Name: Aripiprazole) |
| 2006-700032 (■) | 2987484 | Aripiprazole |
| 2006-700031 (○) | 2893175 | Aripiprazole (Sale name: Evilify 1%) |
| 2006-700031 (■) | 2893175 | Aripiprazole |
| 2006-700029 (○) | 2944402 | Shirodosin |
| 2006-700029 (■) | 2944402 | Shirodosin |
| 2006-700028 (○) | 2944402 | Shirodosin |
| 2006-700028 (■) | 2944402 | Shirodosin |
| 2006-700027 (○) | 2944402 | Shirodosin |
| 2006-700027 (■) | 2944402 | Shirodosin |
| 2006-700026 (○) | 3397385 | Clopidogrel sulfate |
| 2006-700026 (■) | 3397385 | Clopidogrel sulfate |
| 2006-700025 (○) | 3641584 | Clopidogrel sulfate |
| 2006-700025 (■) | 3641584 | Clopidogrel sulfate |
| 2006-700024 (○) | 3055819 | Clopidogrel sulfate |
| 2006-700024 (■) | 3055819 | Clopidogrel sulfate |
| 2006-700023 (○) | 2945174 | Clopidogrel sulfate |
| 2006-700023 (■) | 2945174 | Clopidogrel sulfate |
| 2006-700022 (○) | 1921791 | Clopidogrel sulfate |
| 2006-700022 (■) | 1921791 | Clopidogrel sulfate |
| 2006-700021 (○) | 3397385 | Clopidogrel sulfate |
| 2006-700020 (○) | 2949366 | Clopidogrel sulfate |
| 2006-700019 (○) | 3641584 | Clopidogrel sulfate |
| 2006-700019 (■) | 3641584 | Clopidogrel sulfate |
| 2006-700018 (○) | 3055819 | Clopidogrel sulfate |
| 2006-700018 (■) | 3055819 | Clopidogrel sulfate |
| 2006-700017 (○) | 2945174 | Clopidogrel sulfate |
| 2006-700017 (■) | 2945174 | Clopidogrel sulfate |
| 2006-700016 (○) | 1921791 | Clopidogrel sulfate |
| 2006-700016 (■) | 1921791 | Clopidogrel sulfate |
| 2006-700015 (○) | 1918281 | Paroxetine |
| 2006-700015 (■) | 1918281 | Paroxetine |
| 2006-700014 (○) | 2606720 | Cyazofamid |
| 2006-700014 (■) | 2606720 | Cyazofamid |
| 2006-700013 (○) | 2018112 | Name of sale: Humeral 2.5 mg |
| 2006-700013 (■) | 2018112 | Name of sale: Humeral 2.5 mg |
| 2006-700012 (○) | 2018112 | Common name: Letrozole Name of sale: Femara |
| 2006-700012 (■) | 2018112 | Common name: Letrozole |
| 2006-700011 (○) | 3346586 | Pharmaceutical composition comprising tosfloxacin tosilate, aluminum potassium sulfate, borax and sodium chloride |
| 2006-700011 (■) | 3346586 | Tosfloxacin tosylate |
| 2006-700006 (○) | 2538422 | Tegafur, Guimeracil and Oteracil Potassium (Product Name: TS-1 Capsule 25) |
| 2006-700006 (■) | 2538422 | Tegafur, Guimeracil and Oteracil Potassium (Product Name: TS-1 Capsule 25) |
| 2006-700005 (○) | 2614164 | Tegafur, Guimeracil and Oteracil Potassium (Product Name: TS-1 Capsule 25) |
| 2006-700005 (■) | 2614164 | Tegafur, Guimeracil and Oteracil Potassium (Product Name: TS-1 Capsule 25) |
| 2006-700004 (○) | 3058351 | General Name: Finasteride Chemical Name: (-)-N-tert-Butyl-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide Chemical Structure : The above-mentioned common name, chemical name and substances shown by chemical structural formulas are all the same substance. |
| 2006-700004 (■) | 3058351 | General Name: Finasteride Chemical Name: (-)-N-tert-Butyl-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide Chemical Structure Items indicated by the above-mentioned common name, chemical name and chemical structural formula are all the same substance. |
| 2006-700003 (○) | 3058351 | General Name: Finasteride Chemical Name: (-)-N-tert-Butyl-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide Chemical Structure : The above-mentioned common name, chemical name and substances shown by chemical structural formulas are all the same substance. |
| 2006-700003 (■) | 3058351 | General Name: Finasteride Chemical Name: (-)-N-tert-Butyl-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide Chemical Structure Items indicated by the above-mentioned common name, chemical name and chemical structural formula are all the same substance. |
| 2006-700002 (○) | 2742409 | General Name: Finasteride Chemical Name: (-)-N-tert-Butyl-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide Chemical Structure : The above-mentioned common name, chemical name and substances shown by chemical structural formulas are all the same substance. |
| 2006-700002 (■) | 2742409 | General Name: Finasteride Chemical Name: (-)-N-tert-Butyl-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide Chemical Structure Items indicated by the above-mentioned common name, chemical name and chemical structural formula are all identical substances. |
| 2006-700001 (○) | 2742409 | General Name: Finasteride Chemical Name: (-)-N-tert-Butyl-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide Chemical Structure : The above-mentioned common name, chemical name and substances shown by chemical structural formulas are all the same substance. |
| 2006-700001 (■) | 2742409 | General Name: Finasteride Chemical Name: (-)-N-tert-Butyl-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide Chemical Structure Items indicated by the above-mentioned common name, chemical name and chemical structural formula are all identical substances. |
| 2006- 700030 (■) | 2893175 | Aripiprazole |
| 2006- 70 030 (○) | 2893175 | Aripiprazole (Sale Name: Aripiprazole) |
